"","From","Entry","Gene.Names","Protein.names","Protein.existence","Annotation","Gene.Ontology..GO.","Gene.Ontology.IDs","Gene.encoded.by"
"1","A0A5F5XCT0","A0A5F5XCT0","A1BG","Alpha-1-B glycoprotein","Predicted","1","extracellular region [GO:0005576]; plasma membrane [GO:0005886]; immune response-regulating signaling pathway [GO:0002764]","GO:0002764; GO:0005576; GO:0005886",NA
"2","M3W0W4","M3W0W4","A1BG","Alpha-1-B glycoprotein","Predicted","1",NA,NA,NA
"3","M3W3E7","M3W3E7","A2M PZP","Alpha-2-macroglobulin","Inferred from homology","1","extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]","GO:0004867; GO:0005615",NA
"4","A0A5F5Y1U9","A0A5F5Y1U9","A2M PZP","Alpha-2-macroglobulin","Inferred from homology","2","extracellular space [GO:0005615]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]; negative regulation of complement activation, lectin pathway [GO:0001869]","GO:0001869; GO:0002020; GO:0004866; GO:0004867; GO:0005102; GO:0005615; GO:0019959; GO:0019966; GO:0043120; GO:0048306",NA
"5","A0A5F5Y328","A0A5F5Y328","A2M PZP","Alpha-2-macroglobulin","Inferred from homology","1","extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]","GO:0004867; GO:0005615",NA
"6","A0A337S3K5","A0A337S3K5","A2ML1","Alpha-2-macroglobulin like 1","Inferred from homology","1","extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]","GO:0004867; GO:0005615",NA
"7","M3WN23","M3WN23","ABCA6","ATP binding cassette subfamily A member 6","Predicted","2","intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]","GO:0005319; GO:0005524; GO:0006869; GO:0016020; GO:0016887; GO:0042626; GO:0043231; GO:0140359",NA
"8","A0A337S6A5","A0A337S6A5","ABCB9","ATP binding cassette subfamily B member 9","Predicted","1","lysosomal membrane [GO:0005765]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]","GO:0005524; GO:0005765; GO:0015440; GO:0016887",NA
"9","A0A337RXE3","A0A337RXE3","ABHD14B","Putative protein-lysine deacylase ABHD14B (Alpha/beta hydrolase domain-containing protein 14B)","Inferred from homology","2","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acyltransferase activity [GO:0016746]; hydrolase activity [GO:0016787]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0016746; GO:0016787; GO:0045944",NA
"10","A0A337SDS2","A0A337SDS2","ABI3BP","ABI family member 3 binding protein","Predicted","2","collagen-containing extracellular matrix [GO:0062023]; interstitial matrix [GO:0005614]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of connective tissue replacement involved in inflammatory response wound healing [GO:1904597]; positive regulation of cardiocyte differentiation [GO:1905209]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005518; GO:0005614; GO:0008201; GO:0008285; GO:0010811; GO:0030198; GO:0062023; GO:1904597; GO:1905209",NA
"11","A0A337S133","A0A337S133","ABRACL","Costars family protein ABRACL (ABRA C-terminal-like protein)","Inferred from homology","1","regulation of actin filament-based process [GO:0032970]","GO:0032970",NA
"12","A0A337S9Y6","A0A337S9Y6","ACADM","Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.7)","Inferred from homology","3","mitochondrial matrix [GO:0005759]; flavin adenine dinucleotide binding [GO:0050660]; medium-chain fatty acyl-CoA dehydrogenase activity [GO:0070991]; fatty acid beta-oxidation [GO:0006635]","GO:0005759; GO:0006635; GO:0050660; GO:0070991",NA
"13","M3W0B5","M3W0B5","ACADSB","Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-methylbutyryl-coenzyme A dehydrogenase)","Inferred from homology","4","mitochondrion [GO:0005739]; 2-methylbutanoyl-CoA dehydrogenase activity [GO:0003853]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]","GO:0003853; GO:0003995; GO:0005739; GO:0006550; GO:0006631; GO:0042802; GO:0050660",NA
"14","A0A5F5XDQ7","A0A5F5XDQ7","ACAN","Aggrecan core protein (Cartilage-specific proteoglycan core protein)","Inferred from homology","2","extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]","GO:0005509; GO:0005540; GO:0005576; GO:0007155; GO:0030246",NA
"15","A0A5F5XYF2","A0A5F5XYF2","ACAT1","Acetyl-CoA acetyltransferase, mitochondrial","Inferred from homology","2","mitochondrion [GO:0005739]; acetyl-CoA C-acyltransferase activity [GO:0003988]; metal ion binding [GO:0046872]","GO:0003988; GO:0005739; GO:0046872",NA
"16","M3VZ88","M3VZ88","ACAT2","acetyl-CoA C-acetyltransferase (EC 2.3.1.9)","Inferred from homology","2","acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]","GO:0016747",NA
"17","A0A5F5XZX3","A0A5F5XZX3","ACAT2","acetyl-CoA C-acetyltransferase (EC 2.3.1.9)","Inferred from homology","2","mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; fatty acid beta-oxidation [GO:0006635]","GO:0003985; GO:0005739; GO:0006635",NA
"18","A0A2I2UTZ7","A0A2I2UTZ7","ACE","Angiotensin-converting enzyme (EC 3.4.-.-)","Inferred from homology","5","endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; male gonad development [GO:0008584]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of systemic arterial blood pressure [GO:0003084]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]","GO:0001822; GO:0002003; GO:0002446; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005764; GO:0005768; GO:0005886; GO:0007283; GO:0008237; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009897; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0031404; GO:0031434; GO:0031711; GO:0038166; GO:0042447; GO:0048167; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:1902033; GO:1903597; GO:2000170",NA
"19","Q56H28","Q56H28","ACE2","Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (EC 3.4.17.-) [Cleaved into: Processed angiotensin-converting enzyme 2]","Evidence at protein level","5","apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]; proteolysis [GO:0006508]","GO:0001618; GO:0004180; GO:0005615; GO:0005737; GO:0005886; GO:0005929; GO:0006508; GO:0008237; GO:0008241; GO:0009986; GO:0016324; GO:0046872",NA
"20","A0A337S319","A0A337S319","ACMSD","2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase)","Inferred from homology","2","cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]; negative regulation of quinolinate biosynthetic process [GO:1904985]; organic cyclic compound metabolic process [GO:1901360]","GO:0001760; GO:0005829; GO:0016787; GO:1901360; GO:1904985",NA
"21","M3VWD8","M3VWD8","ACO1","Cytoplasmic aconitate hydratase (EC 4.2.1.3) (Citrate hydro-lyase) (Iron-responsive element-binding protein 1)","Inferred from homology","4","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]","GO:0003994; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006879; GO:0009791; GO:0010040; GO:0030350; GO:0046872; GO:0050892; GO:0051538; GO:0051539",NA
"22","A0A5F5XXE9","A0A5F5XXE9","ACOX3","Acyl-coenzyme A oxidase","Inferred from homology","2","peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid beta-oxidation [GO:0006635]","GO:0003997; GO:0005777; GO:0006635; GO:0071949",NA
"23","A0A337S8L4","A0A337S8L4","ACP1","Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.2) (EC 3.1.3.48) (Low molecular weight cytosolic acid phosphatase)","Inferred from homology","3","cytoplasm [GO:0005737]; acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]","GO:0003993; GO:0004725; GO:0004726; GO:0005737",NA
"24","A0A337S165","A0A337S165","ACP2","Lysosomal acid phosphatase (EC 3.1.3.2)","Inferred from homology","2","lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]","GO:0005765; GO:0043202",NA
"25","A0A337SAA6","A0A337SAA6","ACP2","Lysosomal acid phosphatase (EC 3.1.3.2)","Inferred from homology","2","lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; acid phosphatase activity [GO:0003993]; lysosome organization [GO:0007040]","GO:0003993; GO:0005764; GO:0005765; GO:0007040; GO:0043202",NA
"26","A0A2I2UHD0","A0A2I2UHD0","ACSL5","Long-chain-fatty-acid--CoA ligase (EC 6.2.1.15) (EC 6.2.1.3) (Acyl-CoA synthetase) (Long-chain acyl-CoA synthetase)","Inferred from homology","3","endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]","GO:0004467; GO:0005524; GO:0005741; GO:0005789",NA
"27","A0A5F5XWN0","A0A5F5XWN0","ACTA1 CCSAP","Actin alpha 1, skeletal muscle","Inferred from homology","2","actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; synapse [GO:0045202]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]","GO:0005737; GO:0005884; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0098973",NA
"28","A0A5F5XDM4","A0A5F5XDM4","ACTB","Actin, cytoplasmic 1 (Beta-actin)","Inferred from homology","1",NA,NA,NA
"29","M3W6I2","M3W6I2","ACTG1","Actin, cytoplasmic 2 (Gamma-actin)","Inferred from homology","5","actin filament [GO:0005884]; apical junction complex [GO:0043296]; axon [GO:0030424]; basal body patch [GO:0120220]; calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; membrane [GO:0016020]; myofibril [GO:0030016]; NuA4 histone acetyltransferase complex [GO:0035267]; phagocytic vesicle [GO:0045335]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; identical protein binding [GO:0042802]; profilin binding [GO:0005522]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; ubiquitin protein ligase binding [GO:0031625]; angiogenesis [GO:0001525]; axonogenesis [GO:0007409]; cell motility [GO:0048870]; cellular response to type II interferon [GO:0071346]; morphogenesis of a polarized epithelium [GO:0001738]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of wound healing [GO:0090303]; protein localization to bicellular tight junction [GO:1902396]; regulation of focal adhesion assembly [GO:0051893]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of transepithelial transport [GO:0150111]; sarcomere organization [GO:0045214]; tight junction assembly [GO:0120192]","GO:0001525; GO:0001738; GO:0005522; GO:0005737; GO:0005884; GO:0007409; GO:0010628; GO:0016020; GO:0019901; GO:0030016; GO:0030335; GO:0030424; GO:0031625; GO:0031941; GO:0035267; GO:0042802; GO:0043296; GO:0044305; GO:0045202; GO:0045214; GO:0045335; GO:0048870; GO:0051492; GO:0051893; GO:0070062; GO:0071346; GO:0090303; GO:0098685; GO:0098973; GO:0120192; GO:0120220; GO:0150111; GO:1900242; GO:1902396",NA
"30","A0A337SCW1","A0A337SCW1","ACTG2","Actin, gamma-enteric smooth muscle (Gamma-2-actin) (Smooth muscle gamma-actin)","Inferred from homology","2","cytoskeleton [GO:0005856]","GO:0005856",NA
"31","A0A2I2U3E4","A0A2I2U3E4","ACTN4","Alpha-actinin-4 (Non-muscle alpha-actinin 4)","Inferred from homology","4","anchoring junction [GO:0070161]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transmembrane transporter binding [GO:0044325]; actin cytoskeleton organization [GO:0030036]; muscle cell development [GO:0055001]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050]","GO:0000977; GO:0001725; GO:0001882; GO:0005509; GO:0005634; GO:0005886; GO:0030018; GO:0030036; GO:0030050; GO:0030054; GO:0030335; GO:0030374; GO:0030864; GO:0031490; GO:0033209; GO:0035357; GO:0042803; GO:0042974; GO:0042995; GO:0044325; GO:0045944; GO:0048384; GO:0048471; GO:0051015; GO:0055001; GO:0070161; GO:1900025; GO:1901224; GO:1990904",NA
"32","M3W8V8","M3W8V8","ACVR1","Serine/threonine-protein kinase receptor (EC 2.7.11.30)","Inferred from homology","5","activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; plasma membrane [GO:0005886]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase binding [GO:1990782]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neural crest cell migration [GO:0001755]; pharyngeal system development [GO:0060037]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412]","GO:0001569; GO:0001701; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003183; GO:0003272; GO:0003274; GO:0003289; GO:0005025; GO:0005524; GO:0005886; GO:0007179; GO:0007281; GO:0007368; GO:0007507; GO:0009953; GO:0016361; GO:0030335; GO:0030501; GO:0030509; GO:0032926; GO:0042803; GO:0045177; GO:0045296; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0050431; GO:0050731; GO:0051145; GO:0060037; GO:0060391; GO:0060412; GO:0060923; GO:0061445; GO:0062043; GO:0070724; GO:0071363; GO:0098821; GO:1990782; GO:2000017; GO:2000134; GO:2001237",NA
"33","A0A337RUC4","A0A337RUC4","ACVR1B","receptor protein serine/threonine kinase (EC 2.7.11.30)","Inferred from homology","2","membrane [GO:0016020]; ATP binding [GO:0005524]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]","GO:0004675; GO:0005524; GO:0016020",NA
"34","M3VUE2","M3VUE2","ACVRL1","Serine/threonine-protein kinase receptor (EC 2.7.11.30)","Inferred from homology","5","BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral pattern formation [GO:0009953]; endocardial cushion morphogenesis [GO:0003203]; endothelial tube morphogenesis [GO:0061154]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of blood pressure [GO:0008217]; retina vasculature development in camera-type eye [GO:0061298]; transforming growth factor beta receptor signaling pathway [GO:0007179]; venous blood vessel development [GO:0060841]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0001525; GO:0001701; GO:0001937; GO:0001938; GO:0001946; GO:0001974; GO:0003203; GO:0005025; GO:0005524; GO:0005886; GO:0007179; GO:0007507; GO:0008217; GO:0009953; GO:0009986; GO:0010629; GO:0016361; GO:0019901; GO:0030308; GO:0030509; GO:0030513; GO:0035313; GO:0035912; GO:0043537; GO:0045602; GO:0045603; GO:0045747; GO:0045766; GO:0045944; GO:0046332; GO:0046872; GO:0048185; GO:0050431; GO:0051895; GO:0060391; GO:0060836; GO:0060841; GO:0061154; GO:0061298; GO:0070724; GO:0071363; GO:0098821; GO:1903348",NA
"35","A0A337RV46","A0A337RV46","ACY1","N-acyl-aliphatic-L-amino acid amidohydrolase (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)","Inferred from homology","2","cytoplasm [GO:0005737]; aminoacylase activity [GO:0004046]; metal ion binding [GO:0046872]; amino acid metabolic process [GO:0006520]","GO:0004046; GO:0005737; GO:0006520; GO:0046872",NA
"36","A0A337SC15","A0A337SC15","ACY1","N-acyl-aliphatic-L-amino acid amidohydrolase (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)","Inferred from homology","2","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; amino acid metabolic process [GO:0006520]","GO:0004046; GO:0005737; GO:0006520; GO:0042802; GO:0046872; GO:0070062",NA
"37","A0A2I2UWI1","A0A2I2UWI1","ADAM10","Disintegrin and metalloproteinase domain-containing protein 10 (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease)","Predicted","3","adherens junction [GO:0005912]; clathrin-coated vesicle [GO:0030136]; Golgi membrane [GO:0000139]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]; proteolysis [GO:0006508]","GO:0000139; GO:0004222; GO:0005912; GO:0006508; GO:0017124; GO:0030136; GO:0046872",NA
"38","A0A2I2V2H3","A0A2I2V2H3","ADAM8","ADAM metallopeptidase domain 8","Predicted","5","alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; cell surface [GO:0009986]; dense core granule membrane [GO:0032127]; phagolysosome [GO:0032010]; podosome [GO:0002102]; specific granule [GO:0042581]; tertiary granule [GO:0070820]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; canonical NF-kappaB signal transduction [GO:0007249]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cellular response to hypoxia [GO:0071456]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibronectin-dependent thymocyte migration [GO:2000415]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; proteolysis [GO:0006508]; regulation of cell-cell adhesion [GO:0022407]","GO:0000902; GO:0001525; GO:0002102; GO:0002523; GO:0002675; GO:0002693; GO:0004222; GO:0005509; GO:0006508; GO:0006954; GO:0007249; GO:0008270; GO:0009986; GO:0010718; GO:0022407; GO:0032010; GO:0032127; GO:0033089; GO:0042581; GO:0043410; GO:0043524; GO:0045089; GO:0045780; GO:0048247; GO:0050839; GO:0051044; GO:0051897; GO:0070245; GO:0070820; GO:0071133; GO:0071456; GO:0098609; GO:2000309; GO:2000391; GO:2000415; GO:2000418",NA
"39","A0A337S9H1","A0A337S9H1","ADAM9","ADAM metallopeptidase domain 9","Predicted","1",NA,NA,NA
"40","M3X5J0","M3X5J0","ADAMTS13","ADAM metallopeptidase with thrombospondin type 1 motif 13","Predicted","2","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0043171; GO:0046872",NA
"41","A0A5F5XCM7","A0A5F5XCM7","ADAMTS2","ADAM metallopeptidase with thrombospondin type 1 motif 2","Predicted","2","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270; GO:0030198; GO:0062023",NA
"42","M3WNU5","M3WNU5","ADAMTSL2","ADAMTS like 2","Predicted","2","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril binding [GO:0050436]; extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005576; GO:0030198; GO:0030512; GO:0031012; GO:0050436; GO:0060481",NA
"43","M3VVC4","M3VVC4","ADAMTSL4","ADAMTS like 4","Predicted","2","extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; protease binding [GO:0002020]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; pigment cell development [GO:0070285]; positive regulation of apoptotic process [GO:0043065]","GO:0002020; GO:0002064; GO:0005576; GO:0005614; GO:0030198; GO:0043065; GO:0070285",NA
"44","A0A337SUP1","A0A337SUP1","ADGRE2","Adhesion G protein-coupled receptor E2","Predicted","2","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005509; GO:0005886; GO:0007166",NA
"45","A0A5F5XF14","A0A5F5XF14","ADGRE5","Adhesion G protein-coupled receptor E5","Predicted","2","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189",NA
"46","A0A2I2UTI9","A0A2I2UTI9","ADGRF5","Adhesion G protein-coupled receptor F5","Inferred from homology","2","plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005886; GO:0007166",NA
"47","A0A2I2UM02","A0A2I2UM02","ADGRG1","Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56)","Inferred from homology","3","extracellular region [GO:0005576]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; nervous system development [GO:0007399]","GO:0004930; GO:0005576; GO:0005886; GO:0007155; GO:0007166; GO:0007399; GO:0008201; GO:0030154; GO:0045121",NA
"48","A0A5F5XG72","A0A5F5XG72","ADGRG1","Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56)","Inferred from homology","4","extracellular region [GO:0005576]; glial limiting end-foot [GO:0097451]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; heparin binding [GO:0008201]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cerebral cortex regionalization [GO:0021796]; hematopoietic stem cell homeostasis [GO:0061484]; layer formation in cerebral cortex [GO:0021819]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron migration [GO:2001223]; neural precursor cell proliferation [GO:0061351]; positive regulation of cell adhesion [GO:0045785]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Rho protein signal transduction [GO:0035025]; protein kinase C signaling [GO:0070528]; Rho protein signal transduction [GO:0007266]; seminiferous tubule development [GO:0072520]; vascular endothelial growth factor production [GO:0010573]","GO:0001525; GO:0004930; GO:0005518; GO:0005576; GO:0005886; GO:0007155; GO:0007166; GO:0007189; GO:0007266; GO:0008201; GO:0008285; GO:0010573; GO:0021796; GO:0021819; GO:0035025; GO:0045121; GO:0045785; GO:0050840; GO:0061351; GO:0061484; GO:0070528; GO:0072520; GO:0097451; GO:2000179; GO:2001223",NA
"49","A0A2I2U088","A0A2I2U088","ADGRG6","Adhesion G protein-coupled receptor G6","Inferred from homology","2","membrane [GO:0016020]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0007166; GO:0016020",NA
"50","A0A2I2UB34","A0A2I2UB34","ADGRL1","Adhesion G protein-coupled receptor L1","Predicted","2","membrane [GO:0016020]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0007166; GO:0016020; GO:0030246",NA
"51","A0A2I2U0D3","A0A2I2U0D3","ADGRL2","Adhesion G protein-coupled receptor L2","Predicted","2","membrane [GO:0016020]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0007166; GO:0016020; GO:0030246",NA
"52","A0A2I2U5R8","A0A2I2U5R8","ADGRL3","Adhesion G protein-coupled receptor L3","Predicted","2","membrane [GO:0016020]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0007166; GO:0016020; GO:0030246",NA
"53","A0A337SL34","A0A337SL34","ADGRL4","Adhesion G protein-coupled receptor L4","Inferred from homology","2","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189",NA
"54","A0A3B0IPC1","A0A3B0IPC1","ADIA","Adiponectin A","Predicted","1","collagen trimer [GO:0005581]; extracellular region [GO:0005576]","GO:0005576; GO:0005581",NA
"55","A0A3B0J2D0","A0A3B0J2D0","ADID","Adiponectin D","Predicted","1","collagen trimer [GO:0005581]; extracellular region [GO:0005576]","GO:0005576; GO:0005581",NA
"56","A0A337SQU4","A0A337SQU4","ADPGK","ADP dependent glucokinase","Predicted","1","endoplasmic reticulum [GO:0005783]; ADP-specific glucokinase activity [GO:0043843]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0005783; GO:0006006; GO:0006096; GO:0043843",NA
"57","A0A2I2U1Z3","A0A2I2U1Z3","AFM","Afamin","Predicted","2","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; vitamin E binding [GO:0008431]; protein stabilization [GO:0050821]; protein transport within extracellular region [GO:0071693]; vitamin transport [GO:0051180]","GO:0005615; GO:0005737; GO:0008431; GO:0046872; GO:0050821; GO:0051180; GO:0071693",NA
"58","M3XC81","M3XC81","AFMID","Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF)","Inferred from homology","3","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]","GO:0004061; GO:0005634; GO:0005737; GO:0005829; GO:0019441; GO:0034354",NA
"59","M3X557","M3X557","AFP","Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin)","Predicted","2","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; small molecule binding [GO:0036094]; ovulation from ovarian follicle [GO:0001542]; progesterone metabolic process [GO:0042448]","GO:0001542; GO:0005615; GO:0005737; GO:0036094; GO:0042448; GO:0046872",NA
"60","A0A5F5XS55","A0A5F5XS55","AGA","Aspartylglucosaminidase","Inferred from homology","2","hydrolase activity [GO:0016787]","GO:0016787",NA
"61","M3X0F1","M3X0F1","AGA","Aspartylglucosaminidase","Inferred from homology","2","cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]","GO:0003948; GO:0005615; GO:0005737; GO:0005764; GO:0005783",NA
"62","Q6KCA0","Q6KCA0","agp","Alpha1-glycoprotein acid","Evidence at transcript level","1","extracellular space [GO:0005615]; acute-phase response [GO:0006953]; regulation of immune system process [GO:0002682]","GO:0002682; GO:0005615; GO:0006953",NA
"63","A0A5F5XI81","A0A5F5XI81","AGRN","Agrin","Predicted","3","basement membrane [GO:0005604]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; laminin binding [GO:0043236]; cell differentiation [GO:0030154]; receptor clustering [GO:0043113]","GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0030154; GO:0043113; GO:0043236",NA
"64","A0A2I2UUP6","A0A2I2UUP6","AGT","Angiotensinogen (Serpin A8)","Inferred from homology","2","extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; vasoconstriction [GO:0042310]","GO:0003081; GO:0004867; GO:0005615; GO:0042310",NA
"65","A0A2I2U551","A0A2I2U551","AHCY","Adenosylhomocysteinase (S-adenosyl-L-homocysteine hydrolase)","Inferred from homology","2","one-carbon metabolic process [GO:0006730]","GO:0006730",NA
"66","A0A337SD37","A0A337SD37","AHSG","Alpha-2-HS-glycoprotein (Fetuin-A)","Predicted","2","extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]","GO:0004869; GO:0005576",NA
"67","A0A5F5XVZ8","A0A5F5XVZ8","AHSG","Alpha-2-HS-glycoprotein (Fetuin-A)","Predicted","2","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; acute-phase response [GO:0006953]; negative regulation of bone mineralization [GO:0030502]; ossification [GO:0001503]; positive regulation of phagocytosis [GO:0050766]; regulation of inflammatory response [GO:0050727]","GO:0001503; GO:0004866; GO:0004869; GO:0005576; GO:0005794; GO:0006953; GO:0030502; GO:0031012; GO:0050727; GO:0050766",NA
"68","A0A5F5XHI8","A0A5F5XHI8","AKR1A1","Aldo-keto reductase family 1 member A1 (EC 1.1.1.19) (EC 1.1.1.2) (EC 1.1.1.20) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (Glucuronolactone reductase) (S-nitroso-CoA reductase)","Inferred from homology","5","apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; synapse [GO:0045202]; aldose reductase (NADPH) activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; L-glucuronate reductase activity [GO:0047939]; S-nitrosoglutathione reductase (NADH) activity [GO:0080007]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; L-ascorbic acid biosynthetic process [GO:0019853]","GO:0004032; GO:0005829; GO:0016324; GO:0019640; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0045202; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0080007; GO:0110095",NA
"69","A0A5F5XWS8","A0A5F5XWS8","AKR1B1","Aldo-keto reductase family 1 member B1 (EC 1.1.1.21) (EC 1.1.1.300) (Aldose reductase)","Inferred from homology","4","cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491]","GO:0005737; GO:0016491",NA
"70","A0A5F5XQC7","A0A5F5XQC7","AKR1C3","NADP-dependent oxidoreductase domain-containing protein","Inferred from homology","2","cytosol [GO:0005829]; aldose reductase (NADPH) activity [GO:0004032]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; ketosteroid monooxygenase activity [GO:0047086]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]","GO:0004032; GO:0005829; GO:0006693; GO:0032052; GO:0042448; GO:0044597; GO:0044598; GO:0047023; GO:0047086",NA
"71","M3WA76","M3WA76","AKR7L","Aldo-keto reductase family 7 like (gene/pseudogene)","Predicted","1","cytoplasm [GO:0005737]; aldo-keto reductase (NADPH) activity [GO:0004033]","GO:0004033; GO:0005737",NA
"72","P49064","P49064","ALB","Albumin (allergen Fel d 2)","Evidence at protein level","5","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; fatty acid binding [GO:0005504]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]; cellular response to calcium ion starvation [GO:0072732]; cellular response to starvation [GO:0009267]; negative regulation of mitochondrial depolarization [GO:0051902]","GO:0003677; GO:0005504; GO:0005615; GO:0005737; GO:0009267; GO:0015643; GO:0030170; GO:0032991; GO:0046872; GO:0051902; GO:0072732; GO:1903981",NA
"73","A0A2I2U7Y0","A0A2I2U7Y0","ALB","Albumin","Predicted","3","cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; exogenous protein binding [GO:0140272]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; protein-folding chaperone binding [GO:0051087]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]; cellular response to calcium ion starvation [GO:0072732]; negative regulation of mitochondrial depolarization [GO:0051902]","GO:0003677; GO:0005504; GO:0005737; GO:0005783; GO:0005794; GO:0015643; GO:0019825; GO:0030170; GO:0032991; GO:0042802; GO:0046872; GO:0051087; GO:0051902; GO:0070062; GO:0072732; GO:0140272; GO:1903981",NA
"74","A0A2I2UX74","A0A2I2UX74","ALCAM","CD166 antigen (Activated leukocyte cell adhesion molecule)","Predicted","2","axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]","GO:0005886; GO:0030424; GO:0030425",NA
"75","M3WAV4","M3WAV4","ALDH1A1","aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3)","Inferred from homology","2","cytosol [GO:0005829]; 3-deoxyglucosone dehydrogenase activity [GO:0106373]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]","GO:0005829; GO:0018479; GO:0030392; GO:0106373; GO:0110095",NA
"76","A0A337RUT4","A0A337RUT4","ALDH1L1","10-formyltetrahydrofolate dehydrogenase (EC 1.5.1.6)","Inferred from homology","3","cytosol [GO:0005829]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]","GO:0004029; GO:0005829; GO:0006730; GO:0009058; GO:0009258; GO:0016155",NA
"77","A0A337STY8","A0A337STY8","ALDH2","Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2)","Inferred from homology","2","mitochondrial matrix [GO:0005759]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","GO:0005759; GO:0016620",NA
"78","A0A337RWN1","A0A337RWN1","ALDH7A1","aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3)","Inferred from homology","2","aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]","GO:0004029; GO:0043878",NA
"79","A0A337S2J9","A0A337S2J9","ALDH8A1","Aldehyde dehydrogenase 8 family member A1","Inferred from homology","1","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","GO:0016620",NA
"80","A0A337SF20","A0A337SF20","ALDH8A1","Aldehyde dehydrogenase 8 family member A1","Inferred from homology","1","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","GO:0016620",NA
"81","M3W1Z4","M3W1Z4","ALDH9A1","4-trimethylaminobutyraldehyde dehydrogenase (EC 1.2.1.19) (EC 1.2.1.3) (EC 1.2.1.46) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1) (Formaldehyde dehydrogenase) (Gamma-aminobutyraldehyde dehydrogenase)","Inferred from homology","5","cytoplasm [GO:0005737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; formaldehyde dehydrogenase activity [GO:0018467]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289]","GO:0005737; GO:0006081; GO:0018467; GO:0019145; GO:0047105; GO:0051289",NA
"82","A0A337S416","A0A337S416","ALDOA","Fructose-bisphosphate aldolase (EC 4.1.2.13)","Inferred from homology","2","I band [GO:0031674]; M band [GO:0031430]; fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]","GO:0004332; GO:0006096; GO:0031430; GO:0031674",NA
"83","A0A5F5XME0","A0A5F5XME0","ALDOB","Fructose-bisphosphate aldolase (EC 4.1.2.13)","Inferred from homology","3","centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; fructose-1-phosphate aldolase activity [GO:0061609]; fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096]","GO:0004332; GO:0005737; GO:0006096; GO:0034451; GO:0061609",NA
"84","A0A337SRA7","A0A337SRA7","ALPI","Alkaline phosphatase (EC 3.1.3.1)","Inferred from homology","3","plasma membrane [GO:0005886]; side of membrane [GO:0098552]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]","GO:0004035; GO:0005886; GO:0046872; GO:0098552",NA
"85","Q29486","Q29486","ALPL","Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)","Evidence at protein level","5","mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462]; bone mineralization [GO:0030282]; dephosphorylation [GO:0016311]; positive regulation of cold-induced thermogenesis [GO:0120162]","GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016311; GO:0016462; GO:0016887; GO:0030282; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0098552; GO:0120162",NA
"86","A0A337SNZ0","A0A337SNZ0","AMN","Protein amnionless","Predicted","1","plasma membrane [GO:0005886]; protein transport [GO:0015031]","GO:0005886; GO:0015031",NA
"87","A0A337SBE3","A0A337SBE3","AMN","Protein amnionless","Predicted","2","plasma membrane [GO:0005886]; protein transport [GO:0015031]","GO:0005886; GO:0015031",NA
"88","A0A5F5Y013","A0A5F5Y013","AMY2B","Alpha-amylase (EC 3.2.1.1)","Inferred from homology","2","alpha-amylase activity [GO:0004556]; cation binding [GO:0043169]; carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005975; GO:0043169",NA
"89","M3X5H0","M3X5H0","AMY2B","Alpha-amylase (EC 3.2.1.1)","Inferred from homology","2","extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005615; GO:0005975; GO:0046872",NA
"90","A0A337SEZ4","A0A337SEZ4","ANGPT2","Angiopoietin-2","Predicted","2","extracellular region [GO:0005576]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]","GO:0001525; GO:0005576; GO:0030154; GO:0046872",NA
"91","M3X749","M3X749","ANGPT4","Angiopoietin 4","Predicted","2","collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]","GO:0005615; GO:0007165; GO:0007219; GO:0016525; GO:0030297; GO:0030971; GO:0043066; GO:0043536; GO:0043537; GO:0045766; GO:0050731; GO:0062023; GO:0071456",NA
"92","A0A5F5XNX6","A0A5F5XNX6","ANGPTL1","Angiopoietin like 1","Predicted","1",NA,NA,NA
"93","M3WA23","M3WA23","ANGPTL2","Angiopoietin like 2","Predicted","1","collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]","GO:0005102; GO:0005615; GO:0062023",NA
"94","M3WET8","M3WET8","ANGPTL3","Angiopoietin like 3","Predicted","3","cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; early endosome [GO:0005769]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; phospholipase inhibitor activity [GO:0004859]; artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; lipid storage [GO:0019915]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; triglyceride homeostasis [GO:0070328]","GO:0004859; GO:0005178; GO:0005615; GO:0005769; GO:0005794; GO:0006071; GO:0006631; GO:0007160; GO:0008083; GO:0008203; GO:0009395; GO:0009986; GO:0019915; GO:0030335; GO:0042632; GO:0045766; GO:0048844; GO:0050996; GO:0055091; GO:0062023; GO:0070328",NA
"95","A0A5F5Y1K1","A0A5F5Y1K1","ANGPTL6","Angiopoietin like 6","Predicted","1","collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; signaling receptor binding [GO:0005102]","GO:0005102; GO:0005615; GO:0030141; GO:0062023",NA
"96","A0A337SS27","A0A337SS27","ANPEP","Aminopeptidase N (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (Microsomal aminopeptidase)","Inferred from homology","4","cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]","GO:0005615; GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0042277; GO:0043171; GO:0070006; GO:0070062",NA
"97","P79171","P79171","ANPEP APN","Aminopeptidase N (AP-N) (fAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13)","Evidence at protein level","5","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]","GO:0001525; GO:0001618; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0030154; GO:0042277; GO:0043171; GO:0070006",NA
"98","A0A337SIV7","A0A337SIV7","ANTXR1","ANTXR cell adhesion molecule 1","Inferred from homology","1","membrane [GO:0016020]; signaling receptor activity [GO:0038023]","GO:0016020; GO:0038023",NA
"99","A0A337SPR7","A0A337SPR7","ANTXR2","ANTXR cell adhesion molecule 2","Predicted","2","membrane [GO:0016020]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]","GO:0016020; GO:0038023; GO:0046872",NA
"100","A0A5F5XLK1","A0A5F5XLK1","ANXA1","Annexin","Inferred from homology","3","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase A2 inhibitor activity [GO:0019834]; adaptive immune response [GO:0002250]","GO:0001891; GO:0002250; GO:0005509; GO:0005544; GO:0005576; GO:0005634; GO:0005737; GO:0005929; GO:0016323; GO:0016324; GO:0016328; GO:0019834",NA
"101","M3W3I3","M3W3I3","ANXA10","Annexin A10","Inferred from homology","2","cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786]","GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0012506",NA
"102","A0A5F5XPA1","A0A5F5XPA1","ANXA11","Annexin","Inferred from homology","4","azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; specific granule [GO:0042581]; spindle [GO:0005819]; vesicle membrane [GO:0012506]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; S100 protein binding [GO:0044548]; cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592]","GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005886; GO:0006909; GO:0008429; GO:0012506; GO:0030496; GO:0032506; GO:0042581; GO:0042582; GO:0044548; GO:0045335; GO:0048306; GO:0051592",NA
"103","M3XFZ3","M3XFZ3","ANXA11","Annexin","Inferred from homology","2","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]","GO:0005509; GO:0005544",NA
"104","A0A337SIG2","A0A337SIG2","ANXA13","Annexin","Inferred from homology","1","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]","GO:0005509; GO:0005544",NA
"105","A0A337SCD2","A0A337SCD2","ANXA2","Annexin","Inferred from homology","5","AnxA2-p11 complex [GO:1990665]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; midbody [GO:0030496]; myelin sheath adaxonal region [GO:0035749]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]; sarcolemma [GO:0042383]; Schmidt-Lanterman incisure [GO:0043220]; vesicle membrane [GO:0012506]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; S100 protein binding [GO:0044548]; serine-type endopeptidase inhibitor activity [GO:0004867]; angiogenesis [GO:0001525]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; epithelial cell apoptotic process [GO:1904019]; fibrinolysis [GO:0042730]; lung development [GO:0030324]; membrane raft assembly [GO:0001765]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of receptor internalization [GO:0002091]; osteoclast development [GO:0036035]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of receptor recycling [GO:0001921]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; regulation of neurogenesis [GO:0050767]; response to activity [GO:0014823]; vesicle budding from membrane [GO:0006900]","GO:0001525; GO:0001533; GO:0001765; GO:0001786; GO:0001921; GO:0002020; GO:0002091; GO:0004867; GO:0005509; GO:0005544; GO:0005546; GO:0005604; GO:0005634; GO:0005737; GO:0005765; GO:0005769; GO:0005811; GO:0005829; GO:0005886; GO:0006900; GO:0007160; GO:0008092; GO:0009986; GO:0010756; GO:0012506; GO:0014823; GO:0016323; GO:0019834; GO:0030199; GO:0030324; GO:0030496; GO:0031340; GO:0031902; GO:0032804; GO:0035749; GO:0036035; GO:0042383; GO:0042730; GO:0042789; GO:0042802; GO:0043220; GO:0044090; GO:0044548; GO:0045121; GO:0045944; GO:0048306; GO:0050767; GO:0070062; GO:0090575; GO:0098797; GO:1904019; GO:1905581; GO:1905602; GO:1990665; GO:1990667",NA
"106","A0A337S137","A0A337S137","ANXA4","Annexin","Inferred from homology","2","zymogen granule membrane [GO:0042589]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]","GO:0005509; GO:0005544; GO:0042589",NA
"107","A0A337S5C0","A0A337S5C0","ANXA5","Annexin","Inferred from homology","2","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; negative regulation of coagulation [GO:0050819]","GO:0005509; GO:0005544; GO:0050819",NA
"108","A0A5F5Y7J8","A0A5F5Y7J8","ANXA5","Annexin","Inferred from homology","2","zymogen granule membrane [GO:0042589]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]","GO:0005509; GO:0005544; GO:0042589",NA
"109","A0A337SBJ0","A0A337SBJ0","ANXA5","Annexin","Inferred from homology","2","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; negative regulation of coagulation [GO:0050819]","GO:0005509; GO:0005544; GO:0050819",NA
"110","A0A337SF88","A0A337SF88","ANXA6","Annexin","Inferred from homology","2","zymogen granule membrane [GO:0042589]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]","GO:0005509; GO:0005544; GO:0042589",NA
"111","A0A5F5XRH7","A0A5F5XRH7","ANXA6","Annexin","Inferred from homology","3","cytoplasm [GO:0005737]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; vesicle membrane [GO:0012506]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated monoatomic ion channel activity [GO:0015276]; phosphatidylserine binding [GO:0001786]; apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; regulation of muscle contraction [GO:0006937]","GO:0001786; GO:0005509; GO:0005525; GO:0005544; GO:0005737; GO:0005739; GO:0005765; GO:0006816; GO:0006937; GO:0012506; GO:0015276; GO:0015485; GO:0031902; GO:0042383; GO:0042470; GO:0042802; GO:0048306; GO:0048471; GO:0051283; GO:0051560; GO:0097190",NA
"112","A0A2I2UN04","A0A2I2UN04","ANXA7","Annexin","Inferred from homology","2","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]","GO:0005509; GO:0005544",NA
"113","A0A2I2U0U5","A0A2I2U0U5","AOC2","Amine oxidase (EC 1.4.3.-)","Inferred from homology","2","plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308]","GO:0005507; GO:0005886; GO:0008131; GO:0009308; GO:0048038",NA
"114","A0A337SWK3","A0A337SWK3","AOC3","Amine oxidase (EC 1.4.3.-)","Inferred from homology","3","early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308]; response to antibiotic [GO:0046677]","GO:0005507; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0008131; GO:0009308; GO:0046677; GO:0048038",NA
"115","A0A2I2U7C2","A0A2I2U7C2","AP1B1","Adaptor related protein complex 1 subunit beta 1","Inferred from homology","1","clathrin adaptor complex [GO:0030131]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0006886; GO:0016192; GO:0030131",NA
"116","A0A337SCH1","A0A337SCH1","APBB1 HPX","Amyloid beta protein binding family B member 1","Predicted","2","amyloid-beta binding [GO:0001540]","GO:0001540",NA
"117","A0A5F5XCW1","A0A5F5XCW1","APBB1 HPX","Amyloid beta protein binding family B member 1","Predicted","1","extracellular region [GO:0005576]","GO:0005576",NA
"118","M3W2J4","M3W2J4","APBB1 HPX","Amyloid beta protein binding family B member 1","Predicted","1","extracellular region [GO:0005576]","GO:0005576",NA
"119","A0A5F5XQY3","A0A5F5XQY3","APLP1","Amyloid beta like protein 1","Inferred from homology","2","endomembrane system [GO:0012505]; membrane [GO:0016020]; heparin binding [GO:0008201]; transition metal ion binding [GO:0046914]","GO:0008201; GO:0012505; GO:0016020; GO:0046914",NA
"120","A0A2I2UM58","A0A2I2UM58","APLP2","Amyloid beta like protein 2","Inferred from homology","2","endomembrane system [GO:0012505]; membrane [GO:0016020]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; transition metal ion binding [GO:0046914]","GO:0004867; GO:0008201; GO:0012505; GO:0016020; GO:0046914",NA
"121","A0A337S837","A0A337S837","APOA1","Apolipoprotein A-I (Apolipoprotein A1)","Inferred from homology","2","high-density lipoprotein particle [GO:0034364]; lipid binding [GO:0008289]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]","GO:0006869; GO:0008203; GO:0008289; GO:0034364; GO:0042157",NA
"122","M3WPG6","M3WPG6","APOA1","Apolipoprotein A-I (Apolipoprotein A1)","Inferred from homology","5","chylomicron [GO:0042627]; endocytic vesicle [GO:0030139]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I receptor binding [GO:0034191]; chemorepellent activity [GO:0045499]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; identical protein binding [GO:0042802]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; acylglycerol homeostasis [GO:0055090]; adrenal gland development [GO:0030325]; blood vessel endothelial cell migration [GO:0043534]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; glucocorticoid metabolic process [GO:0008211]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle remodeling [GO:0034375]; integrin-mediated signaling pathway [GO:0007229]; lipid storage [GO:0019915]; lipoprotein biosynthetic process [GO:0042158]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; phosphatidylcholine biosynthetic process [GO:0006656]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein stabilization [GO:0050821]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein phosphorylation [GO:0001932]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transport [GO:0051180]","GO:0001540; GO:0001932; GO:0001935; GO:0002719; GO:0005543; GO:0006656; GO:0006695; GO:0007186; GO:0007229; GO:0008035; GO:0008203; GO:0008211; GO:0010804; GO:0010875; GO:0010903; GO:0015485; GO:0019899; GO:0019915; GO:0030139; GO:0030300; GO:0030325; GO:0031072; GO:0032489; GO:0032691; GO:0033344; GO:0033700; GO:0034115; GO:0034191; GO:0034361; GO:0034362; GO:0034364; GO:0034366; GO:0034375; GO:0034380; GO:0035025; GO:0042158; GO:0042627; GO:0042632; GO:0042802; GO:0043534; GO:0043691; GO:0045499; GO:0050728; GO:0050766; GO:0050821; GO:0051180; GO:0051496; GO:0055090; GO:0055091; GO:0060228; GO:0060354; GO:0070328; GO:0070508; GO:0070653; GO:0090205; GO:0120020; GO:1900026; GO:1902995; GO:1903561",NA
"123","M3W955","M3W955","APOA4","Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4)","Inferred from homology","4","chylomicron [GO:0042627]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; very-low-density lipoprotein particle [GO:0034361]; cholesterol transfer activity [GO:0120020]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; acylglycerol homeostasis [GO:0055090]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; lipoprotein metabolic process [GO:0042157]; phospholipid efflux [GO:0033700]","GO:0005543; GO:0008203; GO:0033344; GO:0033700; GO:0034361; GO:0034362; GO:0034364; GO:0042157; GO:0042627; GO:0055090; GO:0060228; GO:0120020; GO:1903561",NA
"124","A0A337SHX7","A0A337SHX7","APOB","Apolipoprotein B","Predicted","2","cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lipid transporter activity [GO:0005319]; lipid metabolic process [GO:0006629]","GO:0005319; GO:0005737; GO:0005811; GO:0006629; GO:0034362",NA
"125","P0DM82","P0DM82","APOC1","Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I]","Inferred from homology","3","high-density lipoprotein particle [GO:0034364]; very-low-density lipoprotein particle [GO:0034361]; fatty acid binding [GO:0005504]; phospholipase inhibitor activity [GO:0004859]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle clearance [GO:0034447]","GO:0004859; GO:0005504; GO:0006641; GO:0006869; GO:0010916; GO:0032375; GO:0034361; GO:0034364; GO:0034447; GO:0042157; GO:0050995",NA
"126","M3WNX1","M3WNX1","APOC2","Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2)","Inferred from homology","2","chylomicron [GO:0042627]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; very-low-density lipoprotein particle [GO:0034361]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; lipid catabolic process [GO:0016042]; lipid transport [GO:0006869]; positive regulation of phospholipid catabolic process [GO:0060697]","GO:0006869; GO:0016004; GO:0016042; GO:0034361; GO:0034362; GO:0034364; GO:0042627; GO:0043274; GO:0060697",NA
"127","M3WSC8","M3WSC8","APOC3","Apolipoprotein C-III (Apolipoprotein C3)","Inferred from homology","4","chylomicron [GO:0042627]; intermediate-density lipoprotein particle [GO:0034363]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; high-density lipoprotein particle receptor binding [GO:0070653]; lipase inhibitor activity [GO:0055102]; phospholipid binding [GO:0005543]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; chylomicron remnant clearance [GO:0034382]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; negative regulation of cholesterol import [GO:0060621]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of high-density lipoprotein particle clearance [GO:0010987]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of receptor-mediated endocytosis [GO:0048261]; negative regulation of triglyceride catabolic process [GO:0010897]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; phospholipid efflux [GO:0033700]; regulation of Cdc42 protein signal transduction [GO:0032489]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]","GO:0005543; GO:0007186; GO:0010897; GO:0010903; GO:0010916; GO:0010987; GO:0010989; GO:0019433; GO:0032489; GO:0033344; GO:0033700; GO:0034361; GO:0034363; GO:0034366; GO:0034375; GO:0034382; GO:0042157; GO:0042627; GO:0042632; GO:0045717; GO:0048261; GO:0055102; GO:0060621; GO:0070328; GO:0070653",NA
"128","M3W2V3","M3W2V3","APOC4","Apolipoprotein C-IV (Apolipoprotein C4)","Inferred from homology","2","high-density lipoprotein particle [GO:0034364]; very-low-density lipoprotein particle [GO:0034361]; positive regulation of sequestering of triglyceride [GO:0010890]; triglyceride homeostasis [GO:0070328]","GO:0010890; GO:0034361; GO:0034364; GO:0070328",NA
"129","M3X8P7","M3X8P7","APOD","Apolipoprotein D (Apo-D)","Inferred from homology","3","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]","GO:0000302; GO:0005615; GO:0005737; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0010642; GO:0015485; GO:0042246; GO:0042308; GO:0048471; GO:0048662; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405",NA
"130","A0A5F5XHD8","A0A5F5XHD8","APOH","Beta-2-glycoprotein 1 (Apolipoprotein H) (Beta-2-glycoprotein I)","Predicted","2","heparin binding [GO:0008201]","GO:0008201",NA
"131","A0A5F5XPI7","A0A5F5XPI7","APOH","Beta-2-glycoprotein 1 (Apolipoprotein H) (Beta-2-glycoprotein I)","Predicted","2","heparin binding [GO:0008201]","GO:0008201",NA
"132","A0A2I2U3L7","A0A2I2U3L7","APOM","Apolipoprotein M","Inferred from homology","2","high-density lipoprotein particle [GO:0034364]; lipid transport [GO:0006869]","GO:0006869; GO:0034364",NA
"133","M3W828","M3W828","APOM","Apolipoprotein M","Inferred from homology","3","discoidal high-density lipoprotein particle [GO:0034365]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; antioxidant activity [GO:0016209]; lipid transporter activity [GO:0005319]; phospholipid binding [GO:0005543]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; negative regulation of plasma lipoprotein oxidation [GO:0034445]; reverse cholesterol transport [GO:0043691]","GO:0005319; GO:0005543; GO:0016209; GO:0033344; GO:0034361; GO:0034362; GO:0034364; GO:0034365; GO:0034366; GO:0034375; GO:0034380; GO:0034384; GO:0034445; GO:0042157; GO:0043691",NA
"134","A0A0A0MPX8","A0A0A0MPX8","APP","Amyloid-beta A4 protein","Inferred from homology","5","apical part of cell [GO:0045177]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synaptic vesicle [GO:0008021]; enzyme binding [GO:0019899]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; PTB domain binding [GO:0051425]; receptor ligand activity [GO:0048018]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914]; adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; collateral sprouting in absence of injury [GO:0048669]; cytosolic mRNA polyadenylation [GO:0180011]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular copper ion homeostasis [GO:0006878]; ionotropic glutamate receptor signaling pathway [GO:0035235]; mating behavior [GO:0007617]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron differentiation [GO:0045665]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of chemokine production [GO:0032722]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of glycolytic process [GO:0045821]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multicellular organism growth [GO:0040014]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of presynapse assembly [GO:1905606]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of translation [GO:0006417]; response to oxidative stress [GO:0006979]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synaptic assembly at neuromuscular junction [GO:0051124]; visual learning [GO:0008542]","GO:0000086; GO:0000978; GO:0001774; GO:0001967; GO:0002265; GO:0004867; GO:0005102; GO:0005615; GO:0005641; GO:0005769; GO:0005790; GO:0005794; GO:0005798; GO:0005886; GO:0005905; GO:0005911; GO:0006417; GO:0006878; GO:0006897; GO:0006979; GO:0007219; GO:0007409; GO:0007417; GO:0007617; GO:0008021; GO:0008088; GO:0008201; GO:0008203; GO:0008285; GO:0008344; GO:0008542; GO:0009986; GO:0010629; GO:0010800; GO:0010971; GO:0014005; GO:0016199; GO:0016322; GO:0016358; GO:0019899; GO:0030134; GO:0030198; GO:0030426; GO:0030546; GO:0030900; GO:0031594; GO:0032722; GO:0032731; GO:0032755; GO:0032760; GO:0033138; GO:0035235; GO:0035253; GO:0040014; GO:0042802; GO:0043197; GO:0043198; GO:0043204; GO:0043235; GO:0045121; GO:0045177; GO:0045665; GO:0045821; GO:0045944; GO:0046330; GO:0046914; GO:0048018; GO:0048169; GO:0048471; GO:0048669; GO:0048786; GO:0050729; GO:0050730; GO:0050850; GO:0050885; GO:0051124; GO:0051233; GO:0051402; GO:0051425; GO:0051563; GO:0055037; GO:0070050; GO:0070374; GO:0098815; GO:0150003; GO:0180011; GO:1900272; GO:1900273; GO:1901224; GO:1904646; GO:1905606; GO:1905908; GO:1990000; GO:1990535; GO:2000406",NA
"135","A0A2I2UMH4","A0A2I2UMH4","APRT","Adenine phosphoribosyltransferase (EC 2.4.2.7)","Inferred from homology","3","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; IMP salvage [GO:0032264]; purine ribonucleoside salvage [GO:0006166]","GO:0002055; GO:0003999; GO:0005654; GO:0005737; GO:0005829; GO:0006166; GO:0006168; GO:0007625; GO:0016208; GO:0032263; GO:0032264; GO:0044209",NA
"136","A0A2I2UAM6","A0A2I2UAM6","AQP1","Aquaporin-1 (Aquaporin-CHIP) (Water channel protein for red blood cells and kidney proximal tubule)","Inferred from homology","5","ankyrin-1 complex [GO:0170014]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; sarcolemma [GO:0042383]; ammonium transmembrane transporter activity [GO:0008519]; carbon dioxide transmembrane transporter activity [GO:0035379]; ephrin receptor binding [GO:0046875]; glycerol transmembrane transporter activity [GO:0015168]; identical protein binding [GO:0042802]; intracellularly cGMP-activated cation channel activity [GO:0005223]; nitric oxide transmembrane transporter activity [GO:0030184]; potassium channel activity [GO:0005267]; water channel activity [GO:0015250]; camera-type eye morphogenesis [GO:0048593]; carbon dioxide transmembrane transport [GO:0035378]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to UV [GO:0034644]; cerebrospinal fluid secretion [GO:0033326]; cGMP-mediated signaling [GO:0019934]; corticotropin secretion [GO:0051458]; defense response to Gram-negative bacterium [GO:0050829]; establishment of localization in cell [GO:0051649]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; fibroblast migration [GO:0010761]; glomerular filtration [GO:0003094]; hyperosmotic response [GO:0006972]; intracellular water homeostasis [GO:0009992]; lateral ventricle development [GO:0021670]; lipid digestion [GO:0044241]; metanephric descending thin limb development [GO:0072220]; metanephric glomerulus vasculature development [GO:0072239]; metanephric proximal convoluted tubule segment 2 development [GO:0072232]; metanephric proximal straight tubule development [GO:0072230]; negative regulation of apoptotic process [GO:0043066]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; renal water absorption [GO:0070295]; renal water transport [GO:0003097]; secretory granule organization [GO:0033363]; sensory perception of pain [GO:0019233]; transepithelial water transport [GO:0035377]; wound healing [GO:0042060]","GO:0003094; GO:0003097; GO:0005223; GO:0005267; GO:0005737; GO:0005901; GO:0006972; GO:0008519; GO:0009992; GO:0010761; GO:0010763; GO:0015168; GO:0015250; GO:0016323; GO:0016324; GO:0019233; GO:0019934; GO:0021670; GO:0030157; GO:0030184; GO:0030424; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033363; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042060; GO:0042383; GO:0042476; GO:0042802; GO:0043066; GO:0044241; GO:0045766; GO:0046875; GO:0046878; GO:0048146; GO:0048593; GO:0050829; GO:0051458; GO:0051649; GO:0070062; GO:0070295; GO:0070301; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0072220; GO:0072230; GO:0072232; GO:0072239; GO:0170014",NA
"137","A0A2I2U5A2","A0A2I2U5A2","AQP2","Aquaporin-2 (ADH water channel) (Aquaporin-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct)","Inferred from homology","4","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; lumenal side of membrane [GO:0098576]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; glycerol transmembrane transporter activity [GO:0015168]; water channel activity [GO:0015250]; actin filament organization [GO:0007015]; cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; metanephric collecting duct development [GO:0072205]; protein homotetramerization [GO:0051289]; renal water transport [GO:0003097]; water transport [GO:0006833]","GO:0003097; GO:0005794; GO:0005886; GO:0006833; GO:0007015; GO:0015168; GO:0015250; GO:0016323; GO:0016324; GO:0016328; GO:0030659; GO:0042631; GO:0048471; GO:0051289; GO:0055037; GO:0070062; GO:0071280; GO:0071288; GO:0072205; GO:0098576",NA
"138","M3VUM2","M3VUM2","AREG","Amphiregulin","Predicted","3","cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [GO:0060598]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; ERBB2-EGFR signaling pathway [GO:0038134]; G protein-coupled receptor signaling pathway [GO:0007186]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; response to estradiol [GO:0032355]","GO:0005154; GO:0005615; GO:0005634; GO:0005737; GO:0007173; GO:0007186; GO:0008083; GO:0008284; GO:0009986; GO:0016020; GO:0030297; GO:0032355; GO:0038134; GO:0050731; GO:0060598; GO:0060744; GO:0060749; GO:0060750",NA
"139","A0A2I2U8Y1","A0A2I2U8Y1","ARF3","ADP-ribosylation factor 3","Inferred from homology","2","Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0003924; GO:0005525; GO:0005794; GO:0005886; GO:0006886; GO:0016192",NA
"140","M3VXU3","M3VXU3","ARG1","Arginase (EC 3.5.3.1)","Inferred from homology","2","arginase activity [GO:0004053]; metal ion binding [GO:0046872]; arginine metabolic process [GO:0006525]; urea cycle [GO:0000050]","GO:0000050; GO:0004053; GO:0006525; GO:0046872",NA
"141","A0A2I2UBL3","A0A2I2UBL3","ARHGDIA","Rho GDP-dissociation inhibitor 1 (Rho-GDI alpha)","Inferred from homology","2","cytosol [GO:0005829]; membrane [GO:0016020]; Rho GDP-dissociation inhibitor activity [GO:0005094]; Rho protein signal transduction [GO:0007266]","GO:0005094; GO:0005829; GO:0007266; GO:0016020",NA
"142","A0A2I2UL98","A0A2I2UL98","ARHGDIB","Rho GDP dissociation inhibitor beta","Inferred from homology","2","cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activity [GO:0003924]; Rho GDP-dissociation inhibitor activity [GO:0005094]; small GTPase binding [GO:0031267]; negative regulation of trophoblast cell migration [GO:1901164]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]","GO:0003924; GO:0005094; GO:0005829; GO:0007266; GO:0016020; GO:0031267; GO:0035023; GO:1901164",NA
"143","M3WSL5","M3WSL5","ARPC4","Actin-related protein 2/3 complex subunit 4","Inferred from homology","2","Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]","GO:0005200; GO:0005737; GO:0005885; GO:0019899; GO:0030041; GO:0030674; GO:0034314; GO:0042995; GO:0051015",NA
"144","M3WMY0","M3WMY0","ARPC5","Actin-related protein 2/3 complex subunit 5","Inferred from homology","3","Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; regulation of actin filament polymerization [GO:0030833]","GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0016477; GO:0030027; GO:0030833; GO:0034314; GO:0051015",NA
"145","M3XEH2","M3XEH2","ARRDC1","Arrestin domain containing 1","Inferred from homology","1",NA,NA,NA
"146","A0A5F5Y690","A0A5F5Y690","ARRDC1","Arrestin domain containing 1","Inferred from homology","3","cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886]; arrestin family protein binding [GO:1990763]; identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; extracellular transport [GO:0006858]; extracellular vesicle biogenesis [GO:0140112]; negative regulation of Notch signaling pathway [GO:0045746]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005737; GO:0005886; GO:0006511; GO:0006858; GO:0015031; GO:0016567; GO:0031410; GO:0031625; GO:0042802; GO:0045746; GO:0140112; GO:1903561; GO:1990756; GO:1990763",NA
"147","M3WDK2","M3WDK2","ARSA","Arylsulfatase A","Inferred from homology","1","plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; binding of sperm to zona pellucida [GO:0007339]","GO:0004065; GO:0005886; GO:0007339",NA
"148","A0A5F5XKR0","A0A5F5XKR0","ARSG","Arylsulfatase G","Inferred from homology","1","hydrolase activity [GO:0016787]","GO:0016787",NA
"149","M3XAU5","M3XAU5","ART1","NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase)","Inferred from homology","2","cell surface [GO:0009986]; membrane [GO:0016020]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; nucleotidyltransferase activity [GO:0016779]","GO:0003950; GO:0009986; GO:0016020; GO:0016779; GO:0106274",NA
"150","A0A2I2UC45","A0A2I2UC45","ART3","NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase)","Inferred from homology","2","membrane [GO:0016020]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; nucleotidyltransferase activity [GO:0016779]","GO:0016020; GO:0016779; GO:0106274",NA
"151","M3XDK8","M3XDK8","ART4","NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase)","Inferred from homology","2","NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; nucleotidyltransferase activity [GO:0016779]","GO:0003950; GO:0016779; GO:0106274",NA
"152","A0A2I2V0N3","A0A2I2V0N3","ASAH1","Acid ceramidase (EC 3.5.1.23)","Inferred from homology","3","extracellular region [GO:0005576]; lysosome [GO:0005764]; ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040]; fatty acid metabolic process [GO:0006631]; sphingolipid metabolic process [GO:0006665]","GO:0005576; GO:0005764; GO:0006631; GO:0006665; GO:0017040; GO:0017064; GO:0102121",NA
"153","A0A5F5XFU3","A0A5F5XFU3","ASB1","Ankyrin repeat and SOCS box containing 1","Predicted","2","ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; intracellular signal transduction [GO:0035556]; male genitalia development [GO:0030539]; protein ubiquitination [GO:0016567]","GO:0000151; GO:0016567; GO:0030539; GO:0035556; GO:0061630",NA
"154","A0A337SSG0","A0A337SSG0","ASGR1","Asialoglycoprotein receptor 1","Predicted","1","membrane [GO:0016020]","GO:0016020",NA
"155","A0A337SX21","A0A337SX21","ASGR1","Asialoglycoprotein receptor 1","Predicted","1","membrane [GO:0016020]; carbohydrate binding [GO:0030246]","GO:0016020; GO:0030246",NA
"156","A0A337SAN3","A0A337SAN3","ASGR1","Asialoglycoprotein receptor 1","Predicted","1","membrane [GO:0016020]; carbohydrate binding [GO:0030246]","GO:0016020; GO:0030246",NA
"157","A0A2I2U788","A0A2I2U788","ASL","Argininosuccinate lyase","Inferred from homology","2","argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050]","GO:0000050; GO:0004056; GO:0042450",NA
"158","M3WLS9","M3WLS9","ASPDH","Aspartate dehydrogenase domain-containing protein","Inferred from homology","1","aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661]; NAD biosynthetic process [GO:0009435]","GO:0009435; GO:0033735; GO:0050661",NA
"159","M3WWN6","M3WWN6","ASPN","Asporin","Inferred from homology","2","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; bone mineralization [GO:0030282]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005509; GO:0005615; GO:0030282; GO:0030512; GO:0031012; GO:0070171",NA
"160","M3W3H5","M3W3H5","ASS1","Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)","Inferred from homology","2","argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; urea cycle [GO:0000050]","GO:0000050; GO:0004055; GO:0005524; GO:0006526",NA
"161","M3W551","M3W551","ATOX1","Copper transport protein ATOX1 (Metal transport protein ATX1)","Inferred from homology","2","cytosol [GO:0005829]; copper chaperone activity [GO:0016531]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; copper ion transport [GO:0006825]; intracellular copper ion homeostasis [GO:0006878]","GO:0005829; GO:0006825; GO:0006878; GO:0016531; GO:0032767; GO:1903136",NA
"162","A0A2I2UGY1","A0A2I2UGY1","ATP1A1","Sodium/potassium-transporting ATPase subunit alpha","Inferred from homology","5","apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; organelle membrane [GO:0031090]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; protein-folding chaperone binding [GO:0051087]; steroid hormone binding [GO:1990239]; transmembrane transporter binding [GO:0044325]; cellular response to steroid hormone stimulus [GO:0071383]; heart contraction [GO:0060047]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; osmosensory signaling pathway [GO:0007231]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of the force of heart contraction [GO:0002026]; response to glycoside [GO:1903416]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376]","GO:0002026; GO:0005391; GO:0005524; GO:0005890; GO:0006883; GO:0007231; GO:0008217; GO:0009410; GO:0014069; GO:0016323; GO:0016324; GO:0016328; GO:0016791; GO:0016887; GO:0030007; GO:0030315; GO:0030424; GO:0031090; GO:0031947; GO:0036126; GO:0036376; GO:0042383; GO:0042470; GO:0044325; GO:0045822; GO:0045823; GO:0045989; GO:0046872; GO:0051087; GO:0060047; GO:0071383; GO:0086009; GO:1902600; GO:1903416; GO:1990239; GO:1990573",NA
"163","M3WB86","M3WB86","ATP1B1","Sodium/potassium-transporting ATPase subunit beta","Inferred from homology","5","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; organelle membrane [GO:0031090]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; intracellular calcium ion homeostasis [GO:0006874]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression [GO:0010468]; relaxation of cardiac muscle [GO:0055119]; sodium ion export across plasma membrane [GO:0036376]","GO:0001671; GO:0005391; GO:0005890; GO:0006874; GO:0006883; GO:0007155; GO:0010468; GO:0010882; GO:0014704; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030315; GO:0030674; GO:0031090; GO:0036126; GO:0036376; GO:0046034; GO:0050821; GO:0051117; GO:0055119; GO:0060048; GO:0072659; GO:0086009; GO:1903169; GO:1903278; GO:1903288; GO:1990573",NA
"164","M3WZB0","M3WZB0","ATP5F1A","ATP synthase subunit alpha","Inferred from homology","3","COP9 signalosome [GO:0008180]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; lipid metabolic process [GO:0006629]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]","GO:0001937; GO:0005524; GO:0005754; GO:0005886; GO:0006629; GO:0008180; GO:0015986; GO:0042288; GO:0042776; GO:0043531; GO:0043532; GO:0043536; GO:0045261; GO:0046933",NA
"165","M3WF16","M3WF16","ATP6AP1","ATPase H+ transporting accessory protein 1","Inferred from homology","2","endosome membrane [GO:0010008]; presynapse [GO:0098793]; proton-transporting V-type ATPase complex [GO:0033176]; ATPase activator activity [GO:0001671]; small GTPase binding [GO:0031267]; transporter activator activity [GO:0141109]; cellular response to increased oxygen levels [GO:0036295]; endosome to plasma membrane protein transport [GO:0099638]; intracellular iron ion homeostasis [GO:0006879]; osteoclast development [GO:0036035]; regulation of cellular pH [GO:0030641]; synaptic vesicle lumen acidification [GO:0097401]","GO:0001671; GO:0006879; GO:0010008; GO:0030641; GO:0031267; GO:0033176; GO:0036035; GO:0036295; GO:0097401; GO:0098793; GO:0099638; GO:0141109",NA
"166","A0A337SFQ2","A0A337SFQ2","ATP6AP2","Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (Renin/prorenin receptor)","Predicted","3","autophagosome membrane [GO:0000421]; clathrin-coated vesicle membrane [GO:0030665]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; synaptic vesicle membrane [GO:0030672]; signaling receptor activity [GO:0038023]","GO:0000421; GO:0005765; GO:0005789; GO:0030665; GO:0030672; GO:0032591; GO:0038023",NA
"167","A0A2I2UMK7","A0A2I2UMK7","ATP6V0A1","V-type proton ATPase subunit a","Inferred from homology","2","clathrin-coated vesicle membrane [GO:0030665]; melanosome [GO:0042470]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]","GO:0000220; GO:0030665; GO:0030672; GO:0042470; GO:0046961",NA
"168","A0A5F5XUE7","A0A5F5XUE7","ATP6V0C","V-type proton ATPase proteolipid subunit","Inferred from homology","3","clathrin-coated vesicle membrane [GO:0030665]; membrane [GO:0016020]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter complex [GO:1902495]; vacuolar membrane [GO:0005774]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of Wnt signaling pathway [GO:0030177]","GO:0005774; GO:0016020; GO:0030177; GO:0030665; GO:0030672; GO:0031625; GO:0033179; GO:0046961; GO:1902495",NA
"169","A0A337SG88","A0A337SG88","ATP6V0D1","V-type proton ATPase subunit","Inferred from homology","3","centrosome [GO:0005813]; early endosome [GO:0005769]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; presynapse [GO:0098793]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; transmembrane transporter complex [GO:1902495]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]","GO:0005769; GO:0005813; GO:0006879; GO:0007034; GO:0007035; GO:0016471; GO:0033179; GO:0033181; GO:0036295; GO:0046961; GO:0097401; GO:0098793; GO:1902495",NA
"170","A0A2I2U1C8","A0A2I2U1C8","ATP6V1A","H(+)-transporting two-sector ATPase (EC 7.1.2.2)","Inferred from homology","2","clathrin-coated vesicle membrane [GO:0030665]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]","GO:0005524; GO:0016887; GO:0030665; GO:0033180; GO:0046933; GO:0046961",NA
"171","A0A2I2V4V3","A0A2I2V4V3","ATP6V1B2","Vacuolar proton pump subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B)","Inferred from homology","3","apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; melanosome [GO:0042470]; microvillus [GO:0005902]; ruffle [GO:0001726]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035]","GO:0000221; GO:0001726; GO:0005524; GO:0005829; GO:0005902; GO:0007035; GO:0016324; GO:0030665; GO:0030672; GO:0042470; GO:0046034; GO:0046961; GO:0097401",NA
"172","A0A337SKQ1","A0A337SKQ1","ATP6V1C1","V-type proton ATPase subunit C","Inferred from homology","2","clathrin-coated vesicle membrane [GO:0030665]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; synaptic vesicle membrane [GO:0030672]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]","GO:0030665; GO:0030672; GO:0033180; GO:0046961",NA
"173","A0A337SK67","A0A337SK67","ATP6V1E1","V-type proton ATPase subunit E 1 (V-type proton ATPase subunit e 1) (Vacuolar proton pump subunit E 1)","Inferred from homology","2","clathrin-coated vesicle membrane [GO:0030665]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; synaptic vesicle membrane [GO:0030672]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]","GO:0005886; GO:0030665; GO:0030672; GO:0033178; GO:0046961",NA
"174","A0A2I2V0F1","A0A2I2V0F1","ATP6V1G1","V-type proton ATPase subunit G","Inferred from homology","3","cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter complex [GO:1902495]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; synaptic vesicle lumen acidification [GO:0097401]","GO:0000221; GO:0005765; GO:0005829; GO:0005886; GO:0006879; GO:0016887; GO:0030672; GO:0036295; GO:0046961; GO:0051117; GO:0097401; GO:1902495",NA
"175","A0A337SHV5","A0A337SHV5","ATP6V1H","V-type proton ATPase subunit H","Inferred from homology","2","vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]","GO:0000221; GO:0046961",NA
"176","A0A337SFT2","A0A337SFT2","ATRN","Attractin","Predicted","1","membrane [GO:0016020]; carbohydrate binding [GO:0030246]","GO:0016020; GO:0030246",NA
"177","A0A2I2U5X4","A0A2I2U5X4","AVP","Arginine vasopressin","Inferred from homology","3","extracellular space [GO:0005615]; secretory granule [GO:0030141]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; protein kinase activity [GO:0004672]; V1A vasopressin receptor binding [GO:0031894]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein kinase C signaling [GO:0070528]; symbiont entry into host cell [GO:0046718]; vasoconstriction [GO:0042310]","GO:0004672; GO:0005184; GO:0005185; GO:0005615; GO:0010628; GO:0030141; GO:0031894; GO:0033138; GO:0042310; GO:0043027; GO:0046718; GO:0070371; GO:0070528; GO:0090201",NA
"178","A0A2I2UTQ4","A0A2I2UTQ4","AXL","receptor protein-tyrosine kinase (EC 2.7.10.1)","Inferred from homology","5","actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; phosphatidylserine binding [GO:0001786]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; enzyme-linked receptor protein signaling pathway [GO:0007167]; erythrocyte homeostasis [GO:0034101]; establishment of localization in cell [GO:0051649]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of pinocytosis [GO:0048549]; positive regulation of viral life cycle [GO:1903902]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; vagina development [GO:0060068]","GO:0001618; GO:0001764; GO:0001779; GO:0001786; GO:0001961; GO:0001974; GO:0004714; GO:0005524; GO:0005615; GO:0005886; GO:0006909; GO:0006954; GO:0007167; GO:0007283; GO:0007399; GO:0009986; GO:0010936; GO:0015629; GO:0016477; GO:0021885; GO:0030168; GO:0031668; GO:0032689; GO:0032720; GO:0032825; GO:0032940; GO:0034101; GO:0034446; GO:0035457; GO:0042698; GO:0043066; GO:0043231; GO:0043235; GO:0043524; GO:0048469; GO:0048549; GO:0051250; GO:0051402; GO:0051649; GO:0051897; GO:0060068; GO:0071222; GO:0097028; GO:0097350; GO:1903902; GO:2000669",NA
"179","Q5MGS7","Q5MGS7","B2M","Beta-2-microglobulin","Evidence at protein level","3","extracellular region [GO:0005576]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; MHC class I protein complex [GO:0042612]; MHC class II protein complex [GO:0042613]; MHC class II protein complex binding [GO:0023026]; peptide antigen binding [GO:0042605]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of immune response [GO:0050778]; positive regulation of T cell activation [GO:0050870]","GO:0002474; GO:0002503; GO:0005576; GO:0005765; GO:0006955; GO:0019886; GO:0023026; GO:0031902; GO:0042605; GO:0042612; GO:0042613; GO:0050778; GO:0050870",NA
"180","M3WAQ7","M3WAQ7","B3GNT2","Hexosyltransferase (EC 2.4.1.-)","Inferred from homology","2","Golgi membrane [GO:0000139]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein O-linked glycosylation [GO:0006493]; sensory perception of smell [GO:0007608]","GO:0000139; GO:0006493; GO:0007411; GO:0007608; GO:0008532; GO:0030311; GO:1990830",NA
"181","A0A2I2UH51","A0A2I2UH51","B4GALT1","Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-)","Inferred from homology","3","Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]","GO:0000139; GO:0005975; GO:0006486; GO:0016757; GO:0032580; GO:0046872",NA
"182","A0A5F5XM71","A0A5F5XM71","B4GALT5","Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-)","Inferred from homology","2","Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; protein glycosylation [GO:0006486]","GO:0000139; GO:0005975; GO:0006486; GO:0016757; GO:0032580; GO:0046872",NA
"183","M3WQ57","M3WQ57","B4GAT1","Beta-1,4-glucuronyltransferase 1 (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)","Inferred from homology","3","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; axon guidance [GO:0007411]; protein O-linked mannosylation [GO:0035269]","GO:0000139; GO:0005794; GO:0007411; GO:0015020; GO:0035269; GO:0046872",NA
"184","A0A2I2V0L4","A0A2I2V0L4","BAIAP2","BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2)","Predicted","2","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; membrane [GO:0016020]; ruffle [GO:0001726]; cytoskeletal anchor activity [GO:0008093]; plasma membrane organization [GO:0007009]; regulation of actin cytoskeleton organization [GO:0032956]","GO:0001726; GO:0005737; GO:0005856; GO:0007009; GO:0008093; GO:0016020; GO:0030175; GO:0032956",NA
"185","A0A5F5XSY0","A0A5F5XSY0","BAIAP2L1","BAR/IMD domain containing adaptor protein 2 like 1","Predicted","2","actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proline-rich region binding [GO:0070064]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838]","GO:0005654; GO:0005829; GO:0005886; GO:0007009; GO:0015629; GO:0030838; GO:0051017; GO:0051764; GO:0070064",NA
"186","A0A337S942","A0A337S942","BAMBI","BMP and activin membrane-bound inhibitor homolog","Inferred from homology","3","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; cell migration [GO:0016477]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of cell shape [GO:0008360]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0005109; GO:0005737; GO:0005886; GO:0007179; GO:0008284; GO:0008360; GO:0010718; GO:0016477; GO:0030512; GO:0030514; GO:0045668; GO:0045893; GO:0090263",NA
"187","A0A337STZ5","A0A337STZ5","BASP1","Brain abundant membrane attached signal protein 1","Inferred from homology","1",NA,NA,NA
"188","M3W2U8","M3W2U8","BCAM","Basal cell adhesion molecule (Lutheran blood group)","Predicted","2","cell surface [GO:0009986]; plasma membrane [GO:0005886]; laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]; cell-matrix adhesion [GO:0007160]","GO:0005055; GO:0005886; GO:0007160; GO:0009986; GO:0043236",NA
"189","A0A2I2UQE2","A0A2I2UQE2","BCAT1","Branched-chain-amino-acid aminotransferase (EC 2.6.1.42)","Inferred from homology","3","L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-leucine:2-oxoglutarate aminotransferase activity [GO:0050048]; L-valine transaminase activity [GO:0052655]; amino acid biosynthetic process [GO:0008652]; branched-chain amino acid biosynthetic process [GO:0009082]","GO:0008652; GO:0009082; GO:0050048; GO:0052654; GO:0052655; GO:0052656",NA
"190","A0A2I2U2A7","A0A2I2U2A7","BCORL1","BCL6 corepressor like 1","Inferred from homology","1",NA,NA,NA
"191","A0A5F5XI01","A0A5F5XI01","BDH2","Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.104) (EC 1.1.1.30) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (4-oxo-L-proline reductase) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1)","Inferred from homology","3","cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; siderophore biosynthetic process [GO:0019290]","GO:0003858; GO:0005737; GO:0005829; GO:0006635; GO:0019290; GO:0030855; GO:0051287",NA
"192","A0A5F5XF81","A0A5F5XF81","BGLAP","Osteocalcin","Inferred from homology","3","cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; hormone activity [GO:0005179]; hydroxyapatite binding [GO:0046848]; structural constituent of bone [GO:0008147]; biomineral tissue development [GO:0031214]; bone development [GO:0060348]; osteoblast differentiation [GO:0001649]; regulation of bone mineralization [GO:0030500]; regulation of cellular response to insulin stimulus [GO:1900076]; response to vitamin D [GO:0033280]; response to vitamin K [GO:0032571]","GO:0001649; GO:0005179; GO:0005509; GO:0005576; GO:0005737; GO:0008147; GO:0030500; GO:0031214; GO:0032571; GO:0033280; GO:0046848; GO:0060348; GO:1900076",NA
"193","A0A2I2UZ39","A0A2I2UZ39","BIN1","Bridging integrator 1","Predicted","5","axon [GO:0030424]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lipid tube [GO:0060987]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein-folding chaperone binding [GO:0051087]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell cycle process [GO:0010564]; regulation of endocytosis [GO:0030100]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292]","GO:0000122; GO:0002020; GO:0005543; GO:0005635; GO:0005829; GO:0005856; GO:0005886; GO:0006997; GO:0008021; GO:0008333; GO:0010564; GO:0019828; GO:0030100; GO:0030315; GO:0030424; GO:0030425; GO:0030838; GO:0033292; GO:0042802; GO:0043065; GO:0045664; GO:0048156; GO:0048488; GO:0048711; GO:0051015; GO:0051087; GO:0051647; GO:0060987; GO:0060988; GO:0070063; GO:0086091; GO:0090571; GO:0098978; GO:1901380; GO:1902430; GO:1903946; GO:1904878",NA
"194","A0A337SQ46","A0A337SQ46","BLVRB","Biliverdin reductase B","Predicted","1",NA,NA,NA
"195","M3VVW0","M3VVW0","BLVRB","Biliverdin reductase B","Predicted","1",NA,NA,NA
"196","M3XCQ9","M3XCQ9","BMPR1A","receptor protein serine/threonine kinase (EC 2.7.11.30)","Inferred from homology","5","caveola [GO:0005901]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; angiogenesis [GO:0001525]; atrioventricular node cell development [GO:0060928]; BMP signaling pathway [GO:0030509]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to growth factor stimulus [GO:0071363]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart formation [GO:0060914]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm structural organization [GO:0048352]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0001525; GO:0001649; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003148; GO:0003183; GO:0003186; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0005025; GO:0005524; GO:0005886; GO:0005901; GO:0006955; GO:0007179; GO:0007398; GO:0009897; GO:0009950; GO:0009953; GO:0010629; GO:0014032; GO:0014912; GO:0021953; GO:0021983; GO:0021998; GO:0030324; GO:0030501; GO:0030509; GO:0032915; GO:0035019; GO:0035137; GO:0035912; GO:0036122; GO:0042475; GO:0042733; GO:0042803; GO:0043235; GO:0045669; GO:0045944; GO:0046332; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0050673; GO:0050679; GO:0050768; GO:0051148; GO:0060021; GO:0060045; GO:0060391; GO:0060412; GO:0060914; GO:0060928; GO:0061626; GO:0071363; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:2000772",NA
"197","A0A2I2U0V3","A0A2I2U0V3","BMPR2","receptor protein serine/threonine kinase (EC 2.7.11.30)","Inferred from homology","3","membrane [GO:0016020]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]","GO:0004675; GO:0005524; GO:0016020; GO:0043235; GO:0046872",NA
"198","M3VUA4","M3VUA4","BOC","BOC cell adhesion associated, onco regulated","Predicted","2","axon [GO:0030424]; membrane [GO:0016020]; axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; nervous system development [GO:0007399]","GO:0007399; GO:0007411; GO:0016020; GO:0030424; GO:0098609",NA
"199","M3WM50","M3WM50","BPIFA1","BPI fold-containing family A member 1 (Palate lung and nasal epithelium clone protein)","Inferred from homology","3","extracellular space [GO:0005615]; lipid binding [GO:0008289]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to virus [GO:0051607]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; innate immune response [GO:0045087]; multicellular organismal-level water homeostasis [GO:0050891]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; regulation of sodium ion transmembrane transport [GO:1902305]; surfactant homeostasis [GO:0043129]","GO:0002395; GO:0005615; GO:0008289; GO:0019731; GO:0043129; GO:0045087; GO:0050891; GO:0051607; GO:0061844; GO:1900229; GO:1902305",NA
"200","A0A2I2UYJ3","A0A2I2UYJ3","BPIFC","Bactericidal permeability-increasing protein (BPI)","Predicted","2","extracellular space [GO:0005615]; lipid binding [GO:0008289]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]","GO:0005615; GO:0008289; GO:0045087; GO:0050829",NA
"201","A0A5F5XJH2","A0A5F5XJH2","BROX","BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)","Inferred from homology","1",NA,NA,NA
"202","A0A5F5XRG8","A0A5F5XRG8","BROX","BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)","Inferred from homology","2","nuclear envelope [GO:0005635]; mitotic nuclear membrane reassembly [GO:0007084]","GO:0005635; GO:0007084",NA
"203","A0A337S935","A0A337S935","BRWD1","Bromodomain and WD repeat domain containing 1","Predicted","2","axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0005634; GO:0005730; GO:0005829; GO:0005930; GO:0006357; GO:0007010; GO:0008360; GO:0031514",NA
"204","A0A5F5XCB9","A0A5F5XCB9","BSG","Basigin","Predicted","2","basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; lateral plasma membrane [GO:0016328]; mannose binding [GO:0005537]","GO:0005537; GO:0005789; GO:0016323; GO:0016328",NA
"205","A0A2I2UA49","A0A2I2UA49","BST1","ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.6)","Inferred from homology","2","membrane [GO:0016020]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; transferase activity [GO:0016740]","GO:0016020; GO:0016740; GO:0061809",NA
"206","A0A2I2U769","A0A2I2U769","BST2","Bone marrow stromal cell antigen 2","Predicted","1","cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; metalloendopeptidase inhibitor activity [GO:0008191]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]","GO:0005794; GO:0008191; GO:0009986; GO:0016020; GO:0045087; GO:0051607",NA
"207","A0A2I2U4L9","A0A2I2U4L9","BTD","Biotinidase (EC 3.5.1.12)","Inferred from homology","2","membrane [GO:0016020]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; biotin metabolic process [GO:0006768]","GO:0006768; GO:0016020; GO:0016811",NA
"208","A0A337SAQ9","A0A337SAQ9","BTLA","B and T lymphocyte associated","Predicted","1","plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]","GO:0002768; GO:0005886; GO:0038023",NA
"209","A0A2I2V139","A0A2I2V139","C19orf33","Chromosome 19 open reading frame 33","Predicted","1","cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]","GO:0005654; GO:0005730; GO:0005829; GO:0005886",NA
"210","M3WS63","M3WS63","C1QA","Complement C1q subcomponent subunit A","Predicted","2","collagen trimer [GO:0005581]; complement component C1q complex [GO:0062167]; postsynapse [GO:0098794]; astrocyte activation [GO:0048143]; complement activation, classical pathway [GO:0006958]; complement-mediated synapse pruning [GO:0150062]; microglial cell activation [GO:0001774]; neuron remodeling [GO:0016322]; vertebrate eye-specific patterning [GO:0150064]","GO:0001774; GO:0005581; GO:0006958; GO:0016322; GO:0048143; GO:0062167; GO:0098794; GO:0150062; GO:0150064",NA
"211","A0A337SJG7","A0A337SJG7","C1QC","Complement C1q C chain","Predicted","2","collagen trimer [GO:0005581]; complement component C1q complex [GO:0062167]; postsynapse [GO:0098794]; complement activation, classical pathway [GO:0006958]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of macrophage differentiation [GO:0045650]; synapse pruning [GO:0098883]","GO:0005581; GO:0006958; GO:0030853; GO:0045650; GO:0062167; GO:0098794; GO:0098883",NA
"212","A0A5F5XD66","A0A5F5XD66","C1QTNF5","C1q and TNF related 5","Predicted","1","collagen trimer [GO:0005581]; extracellular region [GO:0005576]","GO:0005576; GO:0005581",NA
"213","A0A337SDE6","A0A337SDE6","C1R","complement subcomponent C1r (EC 3.4.21.41)","Predicted","3","extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]","GO:0004252; GO:0005509; GO:0005615; GO:0006958; GO:0031638; GO:0045087",NA
"214","A0A337S217","A0A337S217","C1R","CUB domain-containing protein","Predicted","1","calcium ion binding [GO:0005509]; serine-type peptidase activity [GO:0008236]","GO:0005509; GO:0008236",NA
"215","A0A5F5XHF5","A0A5F5XHF5","C1S","Complement C1s","Predicted","2","extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]","GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0006958; GO:0042802; GO:0045087",NA
"216","A0A2I2V4P2","A0A2I2V4P2","C2","Complement C2 (EC 3.4.21.43) (C3/C5 convertase)","Predicted","3","extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0006958; GO:0045087",NA
"217","A0A5F5Y0X6","A0A5F5Y0X6","C4BPA","Complement component 4 binding protein alpha","Predicted","1",NA,NA,NA
"218","A0A5F5Y5F1","A0A5F5Y5F1","C4BPA","Complement component 4 binding protein alpha","Predicted","1",NA,NA,NA
"219","M3WJK3","M3WJK3","C4BPA","Complement component 4 binding protein alpha","Predicted","1",NA,NA,NA
"220","A0A5F5Y442","A0A5F5Y442","C4BPA","Complement component 4 binding protein alpha","Predicted","1","extracellular space [GO:0005615]; plasma membrane [GO:0005886]; negative regulation of complement activation, classical pathway [GO:0045959]; T cell mediated immunity [GO:0002456]","GO:0002456; GO:0005615; GO:0005886; GO:0045959",NA
"221","M3WJK2","M3WJK2","C4BPB","Complement component 4 binding protein beta","Predicted","2","extracellular space [GO:0005615]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of protein catabolic process [GO:0045732]; regulation of opsonization [GO:1903027]; response to symbiotic bacterium [GO:0009609]","GO:0005615; GO:0009609; GO:0045732; GO:0045959; GO:1903027",NA
"222","M3VV58","M3VV58","C5","Complement C5","Predicted","2","extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; endopeptidase inhibitor activity [GO:0004866]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of chemokine production [GO:0032722]; positive regulation of vascular endothelial growth factor production [GO:0010575]","GO:0004866; GO:0005579; GO:0005615; GO:0006954; GO:0006957; GO:0006958; GO:0010575; GO:0010760; GO:0032722",NA
"223","M3WLH3","M3WLH3","C6","Complement component C6","Inferred from homology","3","extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]","GO:0001701; GO:0005579; GO:0005615; GO:0006956; GO:0006958; GO:0031640; GO:0045087",NA
"224","A0A5F5XTG9","A0A5F5XTG9","C7","Complement C7","Inferred from homology","2","extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]","GO:0005576; GO:0005579; GO:0006958; GO:0031640; GO:0045087",NA
"225","A0A5F5XPJ5","A0A5F5XPJ5","C8A","Complement C8 alpha chain","Inferred from homology","2","extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]","GO:0005579; GO:0005615; GO:0006956; GO:0006958; GO:0031640; GO:0045087",NA
"226","M3W158","M3W158","C8A","Complement C8 alpha chain","Inferred from homology","2","extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]","GO:0005576; GO:0005579; GO:0006958; GO:0031640; GO:0045087",NA
"227","A0A2I2U5W5","A0A2I2U5W5","C8B","Complement component C8 beta chain (Complement component 8 subunit beta)","Inferred from homology","2","extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; killing of cells of another organism [GO:0031640]","GO:0005579; GO:0005615; GO:0006956; GO:0006957; GO:0006958; GO:0031640",NA
"228","M3VUN7","M3VUN7","C8G","Complement C8 gamma chain","Inferred from homology","2","extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; complement binding [GO:0001848]; complement activation [GO:0006956]","GO:0001848; GO:0005576; GO:0005579; GO:0006956",NA
"229","M3WI95","M3WI95","C9","Complement component C9","Inferred from homology","3","extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; other organism cell membrane [GO:0044218]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; killing of cells of another organism [GO:0031640]; protein homooligomerization [GO:0051260]","GO:0005579; GO:0005615; GO:0006956; GO:0006957; GO:0006958; GO:0031640; GO:0044218; GO:0051260",NA
"230","A0A2I2U5V0","A0A2I2U5V0","CA12","Carbonic anhydrase (EC 4.2.1.1)","Inferred from homology","2","membrane [GO:0016020]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]","GO:0004089; GO:0008270; GO:0016020",NA
"231","A0A5F5XSK3","A0A5F5XSK3","CA14","Carbonic anhydrase 14","Inferred from homology","1","plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]","GO:0004089; GO:0005886; GO:0006730; GO:0008270",NA
"232","A0A5F5Y3X9","A0A5F5Y3X9","CA15","carbonic anhydrase (EC 4.2.1.1)","Inferred from homology","2","plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]","GO:0004089; GO:0005886; GO:0006730; GO:0008270",NA
"233","M3WTZ2","M3WTZ2","CA1H5orf15","Chromosome A1 C5orf15 homolog","Predicted","1","membrane [GO:0016020]","GO:0016020",NA
"234","A0A5F5XMJ0","A0A5F5XMJ0","CA2","Carbonic anhydrase (EC 4.2.1.1)","Inferred from homology","3","apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; one-carbon metabolic process [GO:0006730]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]","GO:0004064; GO:0004089; GO:0005737; GO:0005886; GO:0006730; GO:0008270; GO:0015670; GO:0018820; GO:0038166; GO:0044070; GO:0045177; GO:0051453",NA
"235","M3WS40","M3WS40","CA3","Carbonic anhydrase (EC 4.2.1.1)","Inferred from homology","2","cytoplasm [GO:0005737]; cytosol [GO:0005829]; carbonate dehydratase activity [GO:0004089]; nickel cation binding [GO:0016151]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]; response to bacterium [GO:0009617]","GO:0004089; GO:0005737; GO:0005829; GO:0006730; GO:0008270; GO:0009617; GO:0016151",NA
"236","M3WAR8","M3WAR8","CA4","Carbonic anhydrase (EC 4.2.1.1)","Inferred from homology","4","apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]; one-carbon metabolic process [GO:0006730]","GO:0004089; GO:0005791; GO:0005793; GO:0005802; GO:0005886; GO:0006730; GO:0008270; GO:0009897; GO:0015701; GO:0016324; GO:0030658; GO:0030667; GO:0031526; GO:0048471; GO:0070062",NA
"237","A0A2I2U448","A0A2I2U448","CAB39","Calcium binding protein 39","Inferred from homology","1",NA,NA,NA
"238","M3WKE5","M3WKE5","CAB39L","Calcium binding protein 39 like","Inferred from homology","1",NA,NA,NA
"239","A0A2I2U2E0","A0A2I2U2E0","CACNA2D1","Calcium voltage-gated channel auxiliary subunit alpha2delta 1","Inferred from homology","1","monoatomic ion channel complex [GO:0034702]; calcium channel activity [GO:0005262]","GO:0005262; GO:0034702",NA
"240","A0A2I2UR43","A0A2I2UR43","CADM1","Cell adhesion molecule 1","Inferred from homology","1","membrane [GO:0016020]","GO:0016020",NA
"241","A0A2I2UUH5","A0A2I2UUH5","CADM2","Cell adhesion molecule 2","Inferred from homology","1","membrane [GO:0016020]","GO:0016020",NA
"242","M3WMA2","M3WMA2","CADM3","Cell adhesion molecule 3","Inferred from homology","1","membrane [GO:0016020]","GO:0016020",NA
"243","A0A2I2ULF8","A0A2I2ULF8","CADM4","Cell adhesion molecule 4","Inferred from homology","1","membrane [GO:0016020]","GO:0016020",NA
"244","A0A337RZZ8","A0A337RZZ8","CALB1","Calbindin","Inferred from homology","4","cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099567]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; cellular response to organic substance [GO:0071310]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; metanephric collecting duct development [GO:0072205]; metanephric connecting tubule development [GO:0072286]; metanephric distal convoluted tubule development [GO:0072221]; metanephric part of ureteric bud development [GO:0035502]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; retina layer formation [GO:0010842]; short-term memory [GO:0007614]","GO:0005499; GO:0005509; GO:0005634; GO:0005829; GO:0007614; GO:0007616; GO:0007626; GO:0008270; GO:0010842; GO:0030425; GO:0035502; GO:0043025; GO:0043195; GO:0043197; GO:0045202; GO:0071310; GO:0072205; GO:0072221; GO:0072286; GO:0098686; GO:0098978; GO:0098982; GO:0099509; GO:0099534; GO:0099567; GO:1900271",NA
"245","A0A337SVD2","A0A337SVD2","CALM1","EF-hand domain-containing protein","Predicted","1","cytoplasm [GO:0005737]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]","GO:0000922; GO:0005509; GO:0005737",NA
"246","A0A337SJA7","A0A337SJA7","CALM3 CALM2","Calmodulin 2 (Calmodulin 3)","Predicted","1","calcium ion binding [GO:0005509]","GO:0005509",NA
"247","M3VUU7","M3VUU7","CALR","Calreticulin","Inferred from homology","5","cortical granule [GO:0060473]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; integrin binding [GO:0005178]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; ERAD pathway [GO:0036503]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]","GO:0000122; GO:0001849; GO:0002502; GO:0003729; GO:0005049; GO:0005178; GO:0005509; GO:0005615; GO:0005635; GO:0005789; GO:0005829; GO:0005840; GO:0006457; GO:0006611; GO:0008284; GO:0009897; GO:0010595; GO:0010628; GO:0017148; GO:0030246; GO:0030866; GO:0031625; GO:0033018; GO:0033144; GO:0034504; GO:0036503; GO:0040020; GO:0042824; GO:0044322; GO:0045665; GO:0045787; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0060473; GO:0090398; GO:0140313; GO:1900026; GO:1901164; GO:1901224; GO:2000510",NA
"248","A0A2I2U8F6","A0A2I2U8F6","CALR3","Calreticulin","Inferred from homology","2","endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; ERAD pathway [GO:0036503]; protein folding [GO:0006457]","GO:0005509; GO:0005635; GO:0005788; GO:0005789; GO:0006457; GO:0036503; GO:0044183; GO:0051082",NA
"249","A0A2I2U457","A0A2I2U457","CALU","Calumenin","Inferred from homology","2","endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]","GO:0005509; GO:0005789; GO:0005794; GO:0033018; GO:0042470",NA
"250","A0A2I2UC97","A0A2I2UC97","CALU","Calumenin","Inferred from homology","2","extracellular region [GO:0005576]; calcium ion binding [GO:0005509]","GO:0005509; GO:0005576",NA
"251","F1C962","F1C962","CAMP","Cathelicidin","Evidence at transcript level","2","extracellular space [GO:0005615]; specific granule [GO:0042581]; lipopolysaccharide binding [GO:0001530]; amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing by host of symbiont cells [GO:0051873]; neutrophil activation [GO:0042119]","GO:0001530; GO:0002227; GO:0005615; GO:0019731; GO:0042119; GO:0042581; GO:0045087; GO:0050829; GO:0050830; GO:0051873; GO:0061844; GO:1990000",NA
"252","A0A2I2U679","A0A2I2U679","CANT1","Galectin-3-binding protein (Lectin galactoside-binding soluble 3-binding protein)","Predicted","2","extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; nucleoside diphosphate phosphatase activity [GO:0017110]; cell adhesion [GO:0007155]","GO:0005509; GO:0005615; GO:0007155; GO:0016020; GO:0017110",NA
"253","A0A2I2U787","A0A2I2U787","CAP2","Adenylyl cyclase-associated protein","Inferred from homology","3","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; presynaptic actin cytoskeleton organization [GO:0099140]","GO:0000902; GO:0003723; GO:0003779; GO:0005737; GO:0005886; GO:0007015; GO:0008179; GO:0014069; GO:0019933; GO:0042802; GO:0099140",NA
"254","M3XEV5","M3XEV5","CAPN7","Calpain 7","Inferred from homology","2","centrosome [GO:0005813]; cytosol [GO:0005829]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type endopeptidase activity [GO:0004197]; MIT domain binding [GO:0090541]; positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]","GO:0004197; GO:0004198; GO:0005813; GO:0005829; GO:0006508; GO:0010634; GO:0090541; GO:0097264",NA
"255","M3WK60","M3WK60","CAPNS1","Calpain small subunit 1","Predicted","1","calpain complex [GO:0110158]; cytosol [GO:0005829]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]","GO:0004198; GO:0005509; GO:0005829; GO:0016020; GO:0110158",NA
"256","A0M8S9","A0M8S9","CAPZA2","F-actin-capping protein subunit alpha-2 (CapZ alpha-2)","Inferred from homology","2","cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]","GO:0008290; GO:0030036; GO:0030863; GO:0051015; GO:0051016",NA
"257","A0A337S7D7","A0A337S7D7","CAPZB","F-actin-capping protein subunit beta","Inferred from homology","2","cytoplasm [GO:0005737]; F-actin capping protein complex [GO:0008290]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]","GO:0003779; GO:0005737; GO:0008290; GO:0030036; GO:0051016",NA
"258","A0A5F5XBX1","A0A5F5XBX1","CASKIN1","CASK interacting protein 1","Predicted","1",NA,NA,NA
"259","M3X6G1","M3X6G1","CAVIN1","Caveolae associated protein 1","Inferred from homology","3","caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; rRNA primary transcript binding [GO:0042134]; positive regulation of cell motility [GO:2000147]; protein secretion [GO:0009306]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361]","GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005901; GO:0006361; GO:0006363; GO:0009303; GO:0009306; GO:0032991; GO:0042134; GO:0042802; GO:2000147",NA
"260","A0A337S4Q8","A0A337S4Q8","CB4H12orf56","Chromosome B4 C12orf56 homolog","Predicted","1",NA,NA,NA
"261","M3W7W5","M3W7W5","CBLIF","Cobalamin binding intrinsic factor","Inferred from homology","2","apical plasma membrane [GO:0016324]; endosome [GO:0005768]; extracellular space [GO:0005615]; microvillus [GO:0005902]; cargo receptor ligand activity [GO:0140355]; cobalamin binding [GO:0031419]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824]","GO:0005615; GO:0005768; GO:0005902; GO:0006824; GO:0015889; GO:0016324; GO:0031419; GO:0140355",NA
"262","A0A337S4U7","A0A337S4U7","CBLN2","Cerebellin 2","Predicted","1",NA,NA,NA
"263","A0A337SFW3","A0A337SFW3","CCDC126","Coiled-coil domain containing 126","Predicted","1","extracellular region [GO:0005576]","GO:0005576",NA
"264","A0A2I2U794","A0A2I2U794","CCDC150","Coiled-coil domain containing 150","Predicted","1",NA,NA,NA
"265","A0A2I2U1I0","A0A2I2U1I0","CCDC154","Coiled-coil domain containing 154","Predicted","1","bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; odontogenesis of dentin-containing tooth [GO:0042475]; tooth eruption [GO:0044691]","GO:0035630; GO:0042475; GO:0044691; GO:0045453",NA
"266","M3WGB1","M3WGB1","CCDC68","Coiled-coil domain containing 68","Predicted","1","centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; intracellular signal transduction [GO:0035556]; microtubule anchoring at centrosome [GO:0034454]; protein localization [GO:0008104]","GO:0005814; GO:0008104; GO:0034454; GO:0035556; GO:0120103",NA
"267","M3WCI9","M3WCI9","CCL16","C-C motif chemokine","Inferred from homology","2","extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; chemokine-mediated signaling pathway [GO:0070098]; eosinophil chemotaxis [GO:0048245]; inflammatory response [GO:0006954]; positive regulation of cell migration [GO:0030335]","GO:0005615; GO:0006954; GO:0008009; GO:0030335; GO:0042056; GO:0048020; GO:0048245; GO:0061844; GO:0070098",NA
"268","M3WX79","M3WX79","CCN1","CCN family member 1 (Cellular communication network factor 1) (Protein CYR61)","Inferred from homology","5","extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; growth factor binding [GO:0019838]; integrin binding [GO:0005178]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]","GO:0001649; GO:0001934; GO:0002041; GO:0003181; GO:0003278; GO:0003281; GO:0005178; GO:0005615; GO:0007155; GO:0007165; GO:0010811; GO:0019838; GO:0030198; GO:0030335; GO:0030501; GO:0030513; GO:0033690; GO:0043065; GO:0043066; GO:0044319; GO:0045597; GO:0045669; GO:0045944; GO:0050840; GO:0060413; GO:0060591; GO:0060710; GO:0060716; GO:0061036; GO:0070372; GO:0072593; GO:2000304",NA
"269","A0A337S566","A0A337S566","CCN2","CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor)","Inferred from homology","2","extracellular region [GO:0005576]; DNA biosynthetic process [GO:0071897]; signal transduction [GO:0007165]","GO:0005576; GO:0007165; GO:0071897",NA
"270","A0A2I2UV24","A0A2I2UV24","CCN3","CCN family member 3 (Cellular communication network factor 3)","Inferred from homology","2","extracellular region [GO:0005576]; gap junction [GO:0005921]; growth factor activity [GO:0008083]","GO:0005576; GO:0005921; GO:0008083",NA
"271","A0A337SGQ6","A0A337SGQ6","CCN4","Cellular communication network factor 4","Inferred from homology","1","extracellular region [GO:0005576]; signal transduction [GO:0007165]","GO:0005576; GO:0007165",NA
"272","A0A337S736","A0A337S736","CCT4","T-complex protein 1 subunit delta","Inferred from homology","2","chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082]","GO:0005524; GO:0005832; GO:0016887; GO:0051082; GO:0140662",NA
"273","A0A337SB54","A0A337SB54","CD109","CD109 molecule","Inferred from homology","1","extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]","GO:0004867; GO:0005615",NA
"274","M3VWC6","M3VWC6","CD14","Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein)","Predicted","4","external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lipopolysaccharide receptor complex [GO:0046696]; membrane raft [GO:0045121]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; lipoteichoic acid binding [GO:0070891]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of cytokine production [GO:0001819]; positive regulation of endocytosis [GO:0045807]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type II interferon production [GO:0032729]; receptor-mediated endocytosis [GO:0006898]; toll-like receptor 4 signaling pathway [GO:0034142]","GO:0001530; GO:0001819; GO:0001875; GO:0005615; GO:0005794; GO:0006898; GO:0006954; GO:0009897; GO:0031666; GO:0032481; GO:0032729; GO:0032757; GO:0032760; GO:0034142; GO:0034145; GO:0045087; GO:0045121; GO:0045807; GO:0046696; GO:0070891; GO:0071222; GO:0071223; GO:0071726; GO:0071727",NA
"275","M3VZG5","M3VZG5","CD163","CD163 molecule","Predicted","1","external side of plasma membrane [GO:0009897]; scaffold protein binding [GO:0097110]","GO:0009897; GO:0097110",NA
"276","A0A2I2UYP6","A0A2I2UYP6","CD177","CD177 molecule","Predicted","2","plasma membrane raft [GO:0044853]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction maintenance [GO:0045217]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of neutrophil degranulation [GO:0043315]; regulation of integrin-mediated signaling pathway [GO:2001044]","GO:0007159; GO:0043315; GO:0044853; GO:0045217; GO:0098742; GO:2001044",NA
"277","A0A337SMM1","A0A337SMM1","CD1H11orf24","Prostate androgen-regulated mucin-like protein 1","Predicted","2","Golgi apparatus [GO:0005794]; membrane [GO:0016020]","GO:0005794; GO:0016020",NA
"278","A0A2I2U7D8","A0A2I2U7D8","CD1H11orf54","Chromosome D1 C11orf54 homolog","Predicted","1","nucleus [GO:0005634]","GO:0005634",NA
"279","M3W8D8","M3W8D8","CD200","CD200 molecule","Predicted","2","axon [GO:0030424]; cell surface [GO:0009986]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; cell-cell adhesion mediator activity [GO:0098632]; heterotypic cell-cell adhesion [GO:0034113]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; negative regulation of neuroinflammatory response [GO:0150079]; positive regulation of transforming growth factor beta production [GO:0071636]","GO:0009986; GO:0016020; GO:0030424; GO:0034113; GO:0043025; GO:0071636; GO:0098632; GO:0150079; GO:1904465",NA
"280","A0A5F5XNG4","A0A5F5XNG4","CD248","CD248 molecule","Predicted","2","cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; anatomical structure regression [GO:0060033]; cell migration [GO:0016477]; endothelial cell apoptotic process [GO:0072577]; fibroblast migration [GO:0010761]; fibroblast proliferation [GO:0048144]; lymph node development [GO:0048535]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of fibroblast proliferation [GO:0048146]","GO:0005509; GO:0005737; GO:0009897; GO:0010761; GO:0016477; GO:0048144; GO:0048146; GO:0048535; GO:0050840; GO:0060033; GO:0072577; GO:1990430; GO:2000353",NA
"281","A0A5F5Y5L0","A0A5F5Y5L0","CD27","CD27 molecule","Predicted","2","external side of plasma membrane [GO:0009897]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; transmembrane signaling receptor activity [GO:0004888]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of T cell differentiation [GO:0045582]","GO:0004888; GO:0009897; GO:0043027; GO:0043066; GO:0045579; GO:0045582; GO:0097191",NA
"282","A0A2I2UYF4","A0A2I2UYF4","CD276","CD276 molecule","Inferred from homology","2","external side of plasma membrane [GO:0009897]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852]","GO:0001817; GO:0005102; GO:0009897; GO:0050852",NA
"283","M3XCH2","M3XCH2","CD2AP","CD2 associated protein","Predicted","5","cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; growth cone [GO:0030426]; late endosome [GO:0005770]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; slit diaphragm [GO:0036057]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction organization [GO:0045216]; collateral sprouting [GO:0048668]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; filopodium assembly [GO:0046847]; glucose import [GO:0046323]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; localization of cell [GO:0051674]; lymph node development [GO:0048535]; maintenance of blood-brain barrier [GO:0035633]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor signaling pathway [GO:0038180]; neurotrophin TRK receptor signaling pathway [GO:0048011]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; podocyte differentiation [GO:0072112]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of synaptic plasticity [GO:0048167]; renal albumin absorption [GO:0097018]; response to glial cell derived neurotrophic factor [GO:1990790]; response to insulin [GO:0032868]; response to oxidative stress [GO:0006979]; response to transforming growth factor beta [GO:0071559]; response to virus [GO:0009615]; response to wounding [GO:0009611]; stress-activated MAPK cascade [GO:0051403]; synapse organization [GO:0050808]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta1 production [GO:0032905]","GO:0001650; GO:0001726; GO:0001771; GO:0001889; GO:0002102; GO:0003158; GO:0005641; GO:0005737; GO:0005770; GO:0005886; GO:0006629; GO:0006915; GO:0006954; GO:0006979; GO:0007015; GO:0008283; GO:0008584; GO:0009306; GO:0009611; GO:0009615; GO:0016477; GO:0017124; GO:0030041; GO:0030163; GO:0030276; GO:0030425; GO:0030426; GO:0031252; GO:0031594; GO:0031941; GO:0031982; GO:0032482; GO:0032588; GO:0032868; GO:0032905; GO:0032911; GO:0032956; GO:0034451; GO:0035633; GO:0036057; GO:0036312; GO:0038180; GO:0042802; GO:0043491; GO:0043524; GO:0044331; GO:0045216; GO:0046323; GO:0046847; GO:0048011; GO:0048167; GO:0048535; GO:0048668; GO:0050714; GO:0050808; GO:0050852; GO:0051015; GO:0051058; GO:0051291; GO:0051403; GO:0051674; GO:0060612; GO:0061024; GO:0070371; GO:0071559; GO:0072112; GO:0097018; GO:1900182; GO:1990790",NA
"284","A0A337S6R6","A0A337S6R6","CD300LG","CD300 molecule like family member g","Predicted","1","membrane [GO:0016020]","GO:0016020",NA
"285","A0A5F5Y2H9","A0A5F5Y2H9","CD34","CD34 molecule","Predicted","1","membrane [GO:0016020]; cell adhesion [GO:0007155]","GO:0007155; GO:0016020",NA
"286","A0A337S4N5","A0A337S4N5","CD40","Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (CD40L receptor)","Predicted","2","external side of plasma membrane [GO:0009897]; signaling receptor activity [GO:0038023]; B cell activation [GO:0042113]; regulation of immune response [GO:0050776]","GO:0009897; GO:0038023; GO:0042113; GO:0050776",NA
"287","A0A2I2UH63","A0A2I2UH63","CD44","CD44 antigen (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (Phagocytic glycoprotein I)","Predicted","3","extracellular region [GO:0005576]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]","GO:0005540; GO:0005576; GO:0005886; GO:0005902; GO:0007155",NA
"288","A0A337SX28","A0A337SX28","CD47","Leukocyte surface antigen CD47 (Integrin-associated protein)","Predicted","2","plasma membrane [GO:0005886]; thrombospondin receptor activity [GO:0070053]; cell adhesion [GO:0007155]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of inflammatory response [GO:0050729]; positive regulation of phagocytosis [GO:0050766]","GO:0005886; GO:0007155; GO:0022409; GO:0050729; GO:0050766; GO:0070053",NA
"289","A0A5F5XDA0","A0A5F5XDA0","CD58","CD58 molecule","Predicted","1","membrane [GO:0016020]","GO:0016020",NA
"290","A0A5F5XQT8","A0A5F5XQT8","CD59","MAC-inhibitory protein (Membrane attack complex inhibition factor) (Protectin)","Predicted","2","plasma membrane [GO:0005886]; side of membrane [GO:0098552]; complement binding [GO:0001848]; negative regulation of activation of membrane attack complex [GO:0001971]","GO:0001848; GO:0001971; GO:0005886; GO:0098552",NA
"291","A0A1E1GEV5","A0A1E1GEV5","cd5l AIM","CD5 antigen-like","Evidence at transcript level","2","collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; membrane [GO:0016020]; protein-lysine 6-oxidase activity [GO:0004720]; collagen fibril organization [GO:0030199]","GO:0004720; GO:0005615; GO:0016020; GO:0030199; GO:0062023",NA
"292","A0A1E1GEW8","A0A1E1GEW8","cd5l AIM","CD5 antigen-like","Evidence at transcript level","1","membrane [GO:0016020]","GO:0016020",NA
"293","Q76B49","Q76B49","CD63","CD63 antigen (CD antigen CD63)","Evidence at transcript level","4","cell surface [GO:0009986]; extracellular region [GO:0005576]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]","GO:0002092; GO:0005576; GO:0005765; GO:0005886; GO:0007160; GO:0009986; GO:0015031; GO:0016477; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0097487; GO:1900746; GO:2001046",NA
"294","A0A2I2UTM6","A0A2I2UTM6","CD69","CD69 molecule","Predicted","1","external side of plasma membrane [GO:0009897]; protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]","GO:0009897; GO:0030246; GO:0032991; GO:0042802",NA
"295","A0A5F5XTX9","A0A5F5XTX9","CD80","CD80 molecule","Predicted","1","membrane [GO:0016020]","GO:0016020",NA
"296","A0A337S8U6","A0A337S8U6","CD81","CD81 molecule","Inferred from homology","1","plasma membrane [GO:0005886]","GO:0005886",NA
"297","A0A337SBU9","A0A337SBU9","CD82","Tetraspanin","Inferred from homology","2","membrane [GO:0016020]","GO:0016020",NA
"298","A0A337S2I4","A0A337S2I4","CD84","CD84 molecule","Predicted","1","membrane [GO:0016020]","GO:0016020",NA
"299","P40239","P40239","CD9","CD9 antigen (CD antigen CD9)","Evidence at transcript level","4","extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]","GO:0005178; GO:0005576; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0014905; GO:0016020; GO:0030913; GO:0031623; GO:0035036; GO:0071404; GO:0090331",NA
"300","A0A5F5XPS6","A0A5F5XPS6","CD93","CD93 molecule","Predicted","2","cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; complement component C1q complex binding [GO:0001849]; cell-cell adhesion [GO:0098609]","GO:0001849; GO:0005509; GO:0005886; GO:0009986; GO:0031410; GO:0098609",NA
"301","A0A337S9J3","A0A337S9J3","CD99L2","CD99 antigen-like protein 2","Inferred from homology","2","adherens junction [GO:0005912]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; diapedesis [GO:0050904]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of T cell extravasation [GO:2000409]","GO:0005886; GO:0005912; GO:0009986; GO:0050904; GO:2000391; GO:2000409",NA
"302","A0A337SRW5","A0A337SRW5","CDC42","Cell division control protein 42 homolog (EC 3.6.5.2)","Inferred from homology","3","centrosome [GO:0005813]; dendritic spine [GO:0043197]; midbody [GO:0030496]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of cellular component organization [GO:0051130]; regulation of filopodium assembly [GO:0051489]","GO:0003924; GO:0003925; GO:0005525; GO:0005813; GO:0005886; GO:0006897; GO:0007015; GO:0007163; GO:0009653; GO:0019901; GO:0030496; GO:0032488; GO:0043197; GO:0051130; GO:0051489",NA
"303","A0A5F5XFC6","A0A5F5XFC6","CDC5L","Cell division cycle 5 like","Inferred from homology","2","Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0000974; GO:0003677; GO:0005681",NA
"304","A0A337SG59","A0A337SG59","CDH1","Cadherin-1 (Epithelial cadherin)","Predicted","5","adherens junction [GO:0005912]; apical junction complex [GO:0043296]; catenin complex [GO:0016342]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic side of plasma membrane [GO:0009898]; flotillin complex [GO:0016600]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; ankyrin binding [GO:0030506]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; cellular response to indole-3-methanol [GO:0071681]; cellular response to lithium ion [GO:0071285]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; protein localization to plasma membrane [GO:0072659]; synapse assembly [GO:0007416]","GO:0000902; GO:0005509; GO:0005802; GO:0005912; GO:0007043; GO:0007156; GO:0007416; GO:0008013; GO:0009898; GO:0016328; GO:0016339; GO:0016342; GO:0016477; GO:0016600; GO:0022408; GO:0030027; GO:0030336; GO:0030506; GO:0030864; GO:0032794; GO:0034332; GO:0042307; GO:0042802; GO:0043296; GO:0044331; GO:0045295; GO:0045296; GO:0045893; GO:0048471; GO:0071285; GO:0071681; GO:0072659",NA
"305","A0A337S5G0","A0A337S5G0","CDH1","Cadherin-1 (Epithelial cadherin)","Predicted","3","Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005794; GO:0005886; GO:0007156",NA
"306","M3W046","M3W046","CDH11","Cadherin 11","Predicted","3","adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Schaffer collateral - CA1 synapse [GO:0098685]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; corticospinal tract morphogenesis [GO:0021957]; focal adhesion assembly [GO:0048041]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell migration [GO:0030336]","GO:0000902; GO:0005509; GO:0005737; GO:0005912; GO:0007043; GO:0007156; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0021957; GO:0030336; GO:0034332; GO:0044331; GO:0045296; GO:0048041; GO:0050804; GO:0098685; GO:0098978",NA
"307","A0A337SUI1","A0A337SUI1","CDH13","Cadherin 13","Predicted","1","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156",NA
"308","A0A337ST48","A0A337ST48","CDH13","Cadherin 13","Predicted","1","membrane [GO:0016020]; calcium ion binding [GO:0005509]","GO:0005509; GO:0016020",NA
"309","A0A5F5XXK1","A0A5F5XXK1","CDH15","Cadherin 15","Predicted","3","adherens junction [GO:0005912]; catenin complex [GO:0016342]; caveola [GO:0005901]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0000902; GO:0005509; GO:0005794; GO:0005901; GO:0005912; GO:0007043; GO:0007156; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031594; GO:0034332; GO:0044331; GO:0045296",NA
"310","A0A337S9Q3","A0A337S9Q3","CDH16","Cadherin 16","Predicted","2","basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0016323; GO:0016339",NA
"311","A0A5F5Y2W6","A0A5F5Y2W6","CDH17","Cadherin 17","Predicted","1","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156",NA
"312","A0A337SSN3","A0A337SSN3","CDH19","Cadherin 19","Predicted","3","adherens junction [GO:0005912]; catenin complex [GO:0016342]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0034332; GO:0044331; GO:0045296",NA
"313","A0A2I2U9W3","A0A2I2U9W3","CDH2","Cadherin-2 (Neural cadherin)","Predicted","5","adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell surface [GO:0009986]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; fascia adherens [GO:0005916]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; adherens junction organization [GO:0034332]; blood vessel morphogenesis [GO:0048514]; brain morphogenesis [GO:0048854]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homeostasis of number of cells [GO:0048872]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mesenchymal cell migration [GO:0090497]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell development [GO:0014032]; neuroepithelial cell differentiation [GO:0060563]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein localization to plasma membrane [GO:0072659]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; striated muscle cell differentiation [GO:0051146]; synapse assembly [GO:0007416]; synaptic vesicle clustering [GO:0097091]; type B pancreatic cell development [GO:0003323]","GO:0000902; GO:0003323; GO:0003723; GO:0005509; GO:0005737; GO:0005912; GO:0005916; GO:0007043; GO:0007156; GO:0007157; GO:0007416; GO:0008013; GO:0009986; GO:0014032; GO:0014069; GO:0014704; GO:0016323; GO:0016324; GO:0016327; GO:0016339; GO:0016342; GO:0016477; GO:0019901; GO:0019903; GO:0021987; GO:0030027; GO:0030057; GO:0030864; GO:0034332; GO:0042383; GO:0042802; GO:0043005; GO:0043410; GO:0044331; GO:0044853; GO:0045177; GO:0045294; GO:0045295; GO:0045296; GO:0048514; GO:0048787; GO:0048854; GO:0048872; GO:0051146; GO:0060019; GO:0060563; GO:0070445; GO:0072659; GO:0090090; GO:0090497; GO:0097091; GO:0097118; GO:0097150; GO:0099634; GO:1902897; GO:2000809",NA
"314","A0A337SEZ0","A0A337SEZ0","CDH24","Cadherin 24","Predicted","3","adherens junction [GO:0005912]; catenin complex [GO:0016342]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0034332; GO:0044331; GO:0045296",NA
"315","A0A2I2UB75","A0A2I2UB75","CDH3","Cadherin 3","Predicted","4","adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; hair cycle process [GO:0022405]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinization [GO:0031424]; negative regulation of timing of catagen [GO:0051796]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanosome transport [GO:1902910]; retina homeostasis [GO:0001895]","GO:0000902; GO:0001895; GO:0005509; GO:0005737; GO:0005912; GO:0007043; GO:0007156; GO:0008013; GO:0010628; GO:0010838; GO:0016339; GO:0016342; GO:0016477; GO:0022405; GO:0030512; GO:0031424; GO:0034332; GO:0043568; GO:0044331; GO:0045296; GO:0048023; GO:0051796; GO:0090263; GO:1902910",NA
"316","A0A337SGU2","A0A337SGU2","CDH4","Cadherin-4","Predicted","2","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156",NA
"317","M3WM81","M3WM81","CDH5","Cadherin-5 (Vascular endothelial cadherin)","Predicted","2","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156",NA
"318","A0A337SJ76","A0A337SJ76","CDH5","Cadherin domain-containing protein","Predicted","1","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156",NA
"319","A0A337S9H7","A0A337S9H7","CDH6","Cadherin-6","Predicted","2","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156",NA
"320","M3VUL6","M3VUL6","CDH6","Cadherin-6","Predicted","3","adherens junction [GO:0005912]; catenin complex [GO:0016342]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]; synaptic membrane adhesion [GO:0099560]","GO:0000902; GO:0005509; GO:0005654; GO:0005912; GO:0007043; GO:0007156; GO:0007219; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0034332; GO:0044331; GO:0045296; GO:0098978; GO:0099560",NA
"321","A0A2I2USA1","A0A2I2USA1","CDH8","Cadherin 8","Predicted","1","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156",NA
"322","M3VX11","M3VX11","CDHR1","Cadherin-related family member 1 (Photoreceptor cadherin) (Protocadherin-21)","Predicted","3","photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845]","GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0008594; GO:0035845; GO:0042622; GO:0045494",NA
"323","M3VZN4","M3VZN4","CDHR2","Cadherin related family member 2","Predicted","2","apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; microvillus membrane [GO:0031528]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intermicrovillar adhesion [GO:0090675]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; regulation of microvillus length [GO:0032532]","GO:0005509; GO:0007156; GO:0016324; GO:0030855; GO:0031526; GO:0031528; GO:0032532; GO:0044331; GO:0050839; GO:0060243; GO:0090675; GO:0098609",NA
"324","A0A5F5XIV3","A0A5F5XIV3","CDHR5","Cadherin related family member 5","Predicted","2","plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156",NA
"325","A0A5F5Y466","A0A5F5Y466","CDHR5","Cadherin related family member 5","Predicted","2","apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intermicrovillar adhesion [GO:0090675]; regulation of microvillus length [GO:0032532]","GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0008013; GO:0016324; GO:0031526; GO:0031528; GO:0032532; GO:0050839; GO:0090675",NA
"326","A0A2I2V2G8","A0A2I2V2G8","CDON","Cell adhesion associated, onco regulated","Predicted","1","membrane [GO:0016020]","GO:0016020",NA
"327","M3X143","M3X143","CDSN","Corneodesmosin","Predicted","2","extracellular region [GO:0005576]; protein homodimerization activity [GO:0042803]; cell-cell adhesion [GO:0098609]; skin morphogenesis [GO:0043589]","GO:0005576; GO:0042803; GO:0043589; GO:0098609",NA
"328","A0A5F5Y101","A0A5F5Y101","CDSN","Corneodesmosin","Predicted","1",NA,NA,NA
"329","M3WSX6","M3WSX6","CE3H16orf89","Chromosome E3 C16orf89 homolog","Predicted","1","cytosol [GO:0005829]; membrane [GO:0016020]; protein homodimerization activity [GO:0042803]","GO:0005829; GO:0016020; GO:0042803",NA
"330","A0A337S2C9","A0A337S2C9","CEACAM1","Ig-like domain-containing protein","Inferred from homology","2","cell surface [GO:0009986]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165]","GO:0002682; GO:0005886; GO:0007165; GO:0009986; GO:1990782",NA
"331","A0A337RVE0","A0A337RVE0","CEACAM16","CEA cell adhesion molecule 16, tectorial membrane component","Predicted","1","extracellular space [GO:0005615]; stereocilium tip [GO:0032426]; identical protein binding [GO:0042802]; sensory perception of sound [GO:0007605]","GO:0005615; GO:0007605; GO:0032426; GO:0042802",NA
"332","M3VUF8","M3VUF8","CEACAM19","CEA cell adhesion molecule 19","Inferred from homology","1","membrane [GO:0016020]","GO:0016020",NA
"333","M3X096","M3X096","CEL","Carboxylic ester hydrolase (EC 3.1.1.-)","Inferred from homology","2","retinyl-palmitate esterase activity [GO:0050253]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; ceramide catabolic process [GO:0046514]; intestinal cholesterol absorption [GO:0030299]; pancreatic juice secretion [GO:0030157]","GO:0004771; GO:0004806; GO:0030157; GO:0030299; GO:0046514; GO:0050253",NA
"334","Q5R1M5","Q5R1M5","CELA1 ELA1 ELS1","Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1)","Evidence at transcript level","3","extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0046872",NA
"335","M3X2X6","M3X2X6","CENPC","Centromere protein C","Inferred from homology","2","inner kinetochore [GO:0000939]; midbody [GO:0030496]; nuclear body [GO:0016604]; pericentric heterochromatin [GO:0005721]; centromeric DNA binding [GO:0019237]; identical protein binding [GO:0042802]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; kinetochore assembly [GO:0051382]; spindle attachment to meiosis I kinetochore [GO:0051455]","GO:0000939; GO:0005721; GO:0016604; GO:0019237; GO:0030496; GO:0042802; GO:0051315; GO:0051382; GO:0051455",NA
"336","M3W105","M3W105","CES2","Carboxylic ester hydrolase (EC 3.1.1.-)","Inferred from homology","2","intracellular membrane-bounded organelle [GO:0043231]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; prostaglandin metabolic process [GO:0006693]","GO:0006693; GO:0043231; GO:0052689; GO:0106435",NA
"337","A0A337SQR3","A0A337SQR3","CES4A","Carboxylic ester hydrolase (EC 3.1.1.-)","Inferred from homology","2","carboxylic ester hydrolase activity [GO:0052689]","GO:0052689",NA
"338","A0A2I2UFP6","A0A2I2UFP6","CES5A CES1","Carboxylic ester hydrolase (EC 3.1.1.-)","Inferred from homology","2","carboxylic ester hydrolase activity [GO:0052689]","GO:0052689",NA
"339","M3WKH4","M3WKH4","CES5A CES1","Carboxylic ester hydrolase (EC 3.1.1.-)","Inferred from homology","2","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; lipid catabolic process [GO:0016042]","GO:0005783; GO:0005788; GO:0005811; GO:0016042; GO:0052689",NA
"340","Q8I034","Q8I034","CES5A CES7","Carboxylesterase 5A (EC 3.1.1.1) (Carboxylesterase-like urinary excreted protein) (Cauxin)","Evidence at protein level","5","extracellular region [GO:0005576]; carboxylesterase activity [GO:0106435]","GO:0005576; GO:0106435",NA
"341","M3W2B8","M3W2B8","CFB","Complement factor B (EC 3.4.21.47) (C3/C5 convertase)","Predicted","3","extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]","GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006957; GO:0006958; GO:0009617",NA
"342","A0A337SQJ3","A0A337SQJ3","CFD","Complement factor D (EC 3.4.21.46) (Adipsin) (C3 convertase activator) (Properdin factor D)","Predicted","2","serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]","GO:0004252; GO:0006508",NA
"343","M3XG35","M3XG35","CFHR5","Complement factor H related 5","Predicted","2","extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; complement component C3b binding [GO:0001851]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; complement activation [GO:0006956]; cytolysis by host of symbiont cells [GO:0051838]","GO:0001851; GO:0005615; GO:0006956; GO:0032991; GO:0042802; GO:0046982; GO:0051838",NA
"344","A0A2I2U350","A0A2I2U350","CFI","Complement factor I","Predicted","2","membrane [GO:0016020]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; proteolysis [GO:0006508]","GO:0004252; GO:0006508; GO:0006956; GO:0016020",NA
"345","M3WIJ6","M3WIJ6","CFL1","Cofilin-1 (Cofilin, non-muscle isoform)","Inferred from homology","3","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; mitotic cytokinesis [GO:0000281]; positive regulation by host of viral process [GO:0044794]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; response to virus [GO:0009615]","GO:0000281; GO:0005634; GO:0005737; GO:0005925; GO:0009615; GO:0015629; GO:0022604; GO:0030027; GO:0030043; GO:0031258; GO:0032587; GO:0044794; GO:0051014; GO:0051015; GO:0061001",NA
"346","A0A337SEF0","A0A337SEF0","CFL2","Cofilin-2","Inferred from homology","2","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]","GO:0005737; GO:0015629; GO:0030043; GO:0051014; GO:0051015",NA
"347","M3W950","M3W950","CFP","Complement factor properdin","Predicted","1","cytoplasmic side of Golgi membrane [GO:0098548]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; complement activation, alternative pathway [GO:0006957]","GO:0005615; GO:0006957; GO:0030141; GO:0098548",NA
"348","Q52R91","Q52R91","CGA","Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain)","Evidence at transcript level","3","extracellular space [GO:0005615]; follicle-stimulating hormone complex [GO:0016914]; follicle-stimulating hormone activity [GO:0016913]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of steroid biosynthetic process [GO:0010893]; regulation of signaling receptor activity [GO:0010469]; thyroid hormone generation [GO:0006590]","GO:0005615; GO:0006590; GO:0007186; GO:0010469; GO:0010893; GO:0016913; GO:0016914",NA
"349","A0A5F5XGZ4","A0A5F5XGZ4","CGNL1","Cingulin like 1","Predicted","1","myosin complex [GO:0016459]","GO:0016459",NA
"350","A0A337SFJ9","A0A337SFJ9","CHGA","Chromogranin-A","Inferred from homology","2","extracellular region [GO:0005576]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]","GO:0005576; GO:0030133; GO:0030141",NA
"351","A0A5F5XCZ2","A0A5F5XCZ2","CHGA","Chromogranin-A","Inferred from homology","2","extracellular region [GO:0005576]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]","GO:0005576; GO:0030133; GO:0030141",NA
"352","A0A2I2UDB3","A0A2I2UDB3","CHI3L1","Chitinase-3-like protein 1","Inferred from homology","4","endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]","GO:0005576; GO:0005615; GO:0005783; GO:0005975; GO:0006032; GO:0006915; GO:0006954; GO:0008061; GO:0009612; GO:0010800; GO:0030246; GO:0030324; GO:0032757; GO:0034612; GO:0045766; GO:0051897; GO:0070374; GO:0070555; GO:0070741",NA
"353","A0A337SU79","A0A337SU79","CHL1","Cell adhesion molecule L1 like","Inferred from homology","3","apical part of cell [GO:0045177]; axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; protease binding [GO:0002020]; adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; cognition [GO:0050890]; dendrite self-avoidance [GO:0070593]; exploration behavior [GO:0035640]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]","GO:0001764; GO:0002020; GO:0005886; GO:0007156; GO:0007411; GO:0008344; GO:0030424; GO:0030425; GO:0035640; GO:0043524; GO:0045177; GO:0050890; GO:0070593; GO:0098632",NA
"354","M3W0W8","M3W0W8","CHMP2A","Charged multivesicular body protein 2a (Chromatin-modifying protein 2a)","Inferred from homology","5","amphisome membrane [GO:1904930]; chromatin [GO:0000785]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; phosphatidylcholine binding [GO:0031210]; protein domain specific binding [GO:0019904]; autophagosome maturation [GO:0097352]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of centriole elongation [GO:1903723]; nuclear membrane reassembly [GO:0031468]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]","GO:0000776; GO:0000785; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0007080; GO:0010324; GO:0010458; GO:0010824; GO:0015031; GO:0019904; GO:0030117; GO:0030496; GO:0031210; GO:0031468; GO:0032509; GO:0032585; GO:0039702; GO:0043162; GO:0045324; GO:0046761; GO:0051258; GO:0051260; GO:0061952; GO:0097352; GO:1901673; GO:1902774; GO:1903543; GO:1903723; GO:1904930",NA
"355","A0A337S8C4","A0A337S8C4","CHMP2B","Charged multivesicular body protein 2B","Inferred from homology","1","late endosome membrane [GO:0031902]; vacuolar transport [GO:0007034]","GO:0007034; GO:0031902",NA
"356","A0A5F5Y7M8","A0A5F5Y7M8","CHMP3","Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein sorting-associated protein 24)","Inferred from homology","2","late endosome membrane [GO:0031902]; vacuolar transport [GO:0007034]","GO:0007034; GO:0031902",NA
"357","M3WXJ4","M3WXJ4","CHMP4B","Charged multivesicular body protein 4B","Inferred from homology","5","amphisome membrane [GO:1904930]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; protein homodimerization activity [GO:0042803]; autophagosome maturation [GO:0097352]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; maintenance of lens transparency [GO:0036438]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; nervous system process [GO:0050877]; nuclear membrane reassembly [GO:0031468]; plasma membrane repair [GO:0001778]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein polymerization [GO:0051258]; regulation of autophagy [GO:0010506]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]","GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0006620; GO:0006900; GO:0007080; GO:0009898; GO:0010458; GO:0010506; GO:0010824; GO:0030117; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0036438; GO:0039702; GO:0042803; GO:0043162; GO:0046761; GO:0050877; GO:0051258; GO:0061952; GO:0090148; GO:0090611; GO:0097352; GO:1901673; GO:1902774; GO:1904930",NA
"358","M3X6F1","M3X6F1","CHMP5","Charged multivesicular body protein 5 (Chromatin-modifying protein 5)","Inferred from homology","2","vacuolar transport [GO:0007034]","GO:0007034",NA
"359","A0A337SL92","A0A337SL92","CHMP5","Charged multivesicular body protein 5 (Chromatin-modifying protein 5)","Inferred from homology","2","multivesicular body [GO:0005771]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; vesicle budding from membrane [GO:0006900]","GO:0005771; GO:0006900; GO:0032511",NA
"360","A0A337SGE0","A0A337SGE0","CHODL","Chondrolectin","Predicted","2","centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; positive regulation of axonogenesis [GO:0050772]","GO:0005737; GO:0005813; GO:0005829; GO:0016020; GO:0048471; GO:0050772",NA
"361","M3WI48","M3WI48","CHST3","Sulfotransferase (EC 2.8.2.-)","Inferred from homology","3","Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; proteoglycan sulfotransferase activity [GO:0050698]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; T cell homeostasis [GO:0043029]","GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0008459; GO:0030206; GO:0043029; GO:0050698",NA
"362","M3WF53","M3WF53","CILP","Cartilage intermediate layer protein","Predicted","2","collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005615; GO:0010629; GO:0030246; GO:0030512; GO:0043569; GO:0060392; GO:0062023",NA
"363","M3WKI3","M3WKI3","CILP2","Cartilage intermediate layer protein 2","Predicted","1","extracellular space [GO:0005615]","GO:0005615",NA
"364","A0A2I2UED7","A0A2I2UED7","CLASP1","Cytoplasmic linker associated protein 1","Predicted","2","centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule binding [GO:0008017]; negative regulation of cytoskeleton organization [GO:0051494]; negative regulation of supramolecular fiber organization [GO:1902904]; regulation of microtubule polymerization or depolymerization [GO:0031110]","GO:0000776; GO:0005794; GO:0005813; GO:0008017; GO:0031110; GO:0051494; GO:1902904",NA
"365","A0A2I2U6F0","A0A2I2U6F0","CLEC11A","C-type lectin domain containing 11A","Predicted","1","extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; growth factor activity [GO:0008083]; ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284]","GO:0001503; GO:0005615; GO:0008083; GO:0008284; GO:0030246",NA
"366","M3VWY2","M3VWY2","CLEC4G","C-type lectin domain family 4 member G","Predicted","3","external side of plasma membrane [GO:0009897]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; fructose binding [GO:0070061]; mannose binding [GO:0005537]; polysaccharide binding [GO:0030247]; virus coreceptor activity [GO:0120274]; virus receptor activity [GO:0001618]; alpha-beta T cell proliferation [GO:0046633]; immature T cell proliferation in thymus [GO:0033080]; immune response [GO:0006955]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell mediated immunity [GO:0002710]; positive regulation of viral life cycle [GO:1903902]; T cell mediated immunity [GO:0002456]","GO:0001618; GO:0002456; GO:0002710; GO:0005537; GO:0006955; GO:0009897; GO:0030246; GO:0030247; GO:0033080; GO:0033088; GO:0046633; GO:0046642; GO:0070061; GO:0097367; GO:0120274; GO:1903902",NA
"367","A0A2I2UE55","A0A2I2UE55","CLEC7A","C-type lectin domain containing 7A","Predicted","1","membrane [GO:0016020]; (1->3)-beta-D-glucan binding [GO:0001872]; cellular response to molecule of fungal origin [GO:0071226]","GO:0001872; GO:0016020; GO:0071226",NA
"368","A0A337SW69","A0A337SW69","CLEC7A","C-type lectin domain containing 7A","Predicted","1","membrane [GO:0016020]; (1->3)-beta-D-glucan binding [GO:0001872]; cellular response to molecule of fungal origin [GO:0071226]","GO:0001872; GO:0016020; GO:0071226",NA
"369","M3WNY6","M3WNY6","CLIC1","Chloride intracellular channel protein","Inferred from homology","3","chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; chloride transport [GO:0006821]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005254; GO:0005737; GO:0005739; GO:0005783; GO:0005886; GO:0006821; GO:0016020; GO:0031965; GO:0034707; GO:0045669; GO:0048471; GO:0051881; GO:0070062",NA
"370","A0A337SD38","A0A337SD38","CLIC4","Chloride intracellular channel protein","Inferred from homology","4","apical part of cell [GO:0045177]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; microvillus [GO:0005902]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to calcium ion [GO:0071277]; endothelial cell morphogenesis [GO:0001886]; fertilization [GO:0009566]; keratinocyte differentiation [GO:0030216]; multicellular organism growth [GO:0035264]; negative regulation of cell migration [GO:0030336]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuolar acidification [GO:0007035]","GO:0001525; GO:0001886; GO:0005254; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005902; GO:0005911; GO:0007035; GO:0009566; GO:0009986; GO:0016363; GO:0030216; GO:0030336; GO:0030496; GO:0030659; GO:0034707; GO:0035264; GO:0045177; GO:0048471; GO:0048754; GO:0061299; GO:0071277",NA
"371","A0A2I2UVX8","A0A2I2UVX8","CLIC5","Chloride intracellular channel protein","Inferred from homology","2","chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; chloride channel activity [GO:0005254]","GO:0005254; GO:0005737; GO:0034707",NA
"372","M3VW19","M3VW19","CLMP","CXADR like membrane protein","Predicted","2","bicellular tight junction [GO:0005923]; cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020]; digestive tract development [GO:0048565]","GO:0005881; GO:0005923; GO:0016020; GO:0048565",NA
"373","A0A2I2U499","A0A2I2U499","CLN3","Battenin","Inferred from homology","2","lysosomal membrane [GO:0005765]","GO:0005765",NA
"374","A0A2I2UWU9","A0A2I2UWU9","CLN5","Bis(monoacylglycero)phosphate synthase CLN5 (EC 3.1.2.22) (Ceroid-lipofuscinosis neuronal protein 5) (Palmitoyl protein thioesterase CLN5) (S-depalmitoylase CLN5)","Inferred from homology","5","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; vacuolar lumen [GO:0005775]; bis(monoacylglycero)phosphate synthase activity [GO:0160121]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; mannose binding [GO:0005537]; brain development [GO:0007420]; glycosylation [GO:0070085]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; neurogenesis [GO:0022008]; retrograde transport, endosome to Golgi [GO:0042147]; signal peptide processing [GO:0006465]; visual perception [GO:0007601]","GO:0005537; GO:0005765; GO:0005775; GO:0005783; GO:0005794; GO:0005829; GO:0006465; GO:0007040; GO:0007042; GO:0007420; GO:0007601; GO:0016798; GO:0022008; GO:0042147; GO:0048471; GO:0052816; GO:0070085; GO:0160121",NA
"375","M3W2V0","M3W2V0","CLPTM1 APOE","Apolipoprotein E","Inferred from homology","3","chylomicron [GO:0042627]; high-density lipoprotein particle [GO:0034364]; multivesicular body [GO:0005771]; very-low-density lipoprotein particle [GO:0034361]; heparin binding [GO:0008201]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]","GO:0005771; GO:0006869; GO:0008201; GO:0008289; GO:0034361; GO:0034364; GO:0042157; GO:0042627",NA
"376","A0A337S9Y3","A0A337S9Y3","CLPTM1 APOE","Apolipoprotein E","Inferred from homology","3","chylomicron [GO:0042627]; high-density lipoprotein particle [GO:0034364]; multivesicular body [GO:0005771]; very-low-density lipoprotein particle [GO:0034361]; heparin binding [GO:0008201]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]","GO:0005771; GO:0006869; GO:0008201; GO:0008289; GO:0034361; GO:0034364; GO:0042157; GO:0042627",NA
"377","M3VU87","M3VU87","CLSTN3","Calsyntenin-3","Inferred from homology","4","cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cell-cell adhesion mediator activity [GO:0098632]; neurexin family protein binding [GO:0042043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]","GO:0000139; GO:0001558; GO:0005509; GO:0005789; GO:0007156; GO:0007416; GO:0009986; GO:0032991; GO:0035249; GO:0042043; GO:0045211; GO:0050806; GO:0051932; GO:0051965; GO:0098632; GO:0098839; GO:0098978; GO:0098982; GO:1902474; GO:1905606",NA
"378","M3WKP2","M3WKP2","CLU","Clusterin","Inferred from homology","5","apical dendrite [GO:0097440]; cell periphery [GO:0071944]; cell surface [GO:0009986]; chromaffin granule [GO:0042583]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; neurofibrillary tangle [GO:0097418]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum lumen [GO:0099020]; spherical high-density lipoprotein particle [GO:0034366]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle receptor binding [GO:0050750]; misfolded protein binding [GO:0051787]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cell morphogenesis [GO:0000902]; central nervous system myelin maintenance [GO:0032286]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; immune complex clearance [GO:0002434]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neurofibrillary tangle assembly [GO:1902998]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of amyloid-beta clearance [GO:1900221]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of neuronal signal transduction [GO:1902847]; response to misfolded protein [GO:0051788]; response to virus [GO:0009615]","GO:0000902; GO:0001540; GO:0001774; GO:0002434; GO:0005615; GO:0005634; GO:0005743; GO:0005829; GO:0005856; GO:0009615; GO:0009986; GO:0017038; GO:0031333; GO:0031334; GO:0031625; GO:0032286; GO:0032436; GO:0032760; GO:0034366; GO:0042127; GO:0042583; GO:0042981; GO:0043065; GO:0044877; GO:0045202; GO:0045429; GO:0048156; GO:0048260; GO:0050750; GO:0050821; GO:0051082; GO:0051131; GO:0051787; GO:0051788; GO:0061077; GO:0061518; GO:0061740; GO:0071944; GO:0097418; GO:0097440; GO:0099020; GO:0140597; GO:1900221; GO:1902004; GO:1902230; GO:1902430; GO:1902847; GO:1902998; GO:1903573; GO:1905907",NA
"379","A0A5F5XGP3","A0A5F5XGP3","CLU","Clusterin","Inferred from homology","3","chromaffin granule [GO:0042583]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]","GO:0005576; GO:0005634; GO:0005783; GO:0005829; GO:0031966; GO:0042583; GO:0048471",NA
"380","A0A5F5XKE9","A0A5F5XKE9","CMPK2","Cytidine/uridine monophosphate kinase 2","Inferred from homology","1",NA,NA,NA
"381","A0A337SUS1","A0A337SUS1","CNDP2","Carnosine dipeptidase 2","Predicted","1","carboxypeptidase activity [GO:0004180]","GO:0004180",NA
"382","M3W9A2","M3W9A2","CNDP2","Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Threonyl dipeptidase)","Inferred from homology","4","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; proteolysis [GO:0006508]","GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070573",NA
"383","A0A337SGM0","A0A337SGM0","CNNM4 CNNM3","Metal transporter","Inferred from homology","2","plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; magnesium ion homeostasis [GO:0010960]","GO:0005886; GO:0010960; GO:0022857",NA
"384","M3WWG3","M3WWG3","CNP","2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)","Inferred from homology","3","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; myelin sheath [GO:0043209]; 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; oligodendrocyte differentiation [GO:0048709]; response to toxic substance [GO:0009636]","GO:0003723; GO:0004113; GO:0005615; GO:0005737; GO:0007409; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0042470; GO:0043209; GO:0048709",NA
"385","A0A337RVG5","A0A337RVG5","CNTFR","Ciliary neurotrophic factor receptor subunit alpha","Inferred from homology","3","apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; CNTFR-CLCF1 complex [GO:0097059]; external side of plasma membrane [GO:0009897]; ciliary neurotrophic factor receptor activity [GO:0004897]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor binding [GO:0005102]; brainstem development [GO:0003360]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; motor neuron apoptotic process [GO:0097049]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of cell population proliferation [GO:0008284]; sex differentiation [GO:0007548]; skeletal muscle organ development [GO:0060538]; suckling behavior [GO:0001967]","GO:0001967; GO:0003360; GO:0004896; GO:0004897; GO:0005102; GO:0007548; GO:0008284; GO:0009897; GO:0016324; GO:0019955; GO:0060538; GO:0070110; GO:0070120; GO:0097049; GO:0097059; GO:2000672",NA
"386","A0A2I2U968","A0A2I2U968","CNTN1","Contactin-1","Inferred from homology","1","cell adhesion [GO:0007155]","GO:0007155",NA
"387","A0A2I2UN28","A0A2I2UN28","COCH","Cochlin","Predicted","2",NA,NA,NA
"388","M3WFG2","M3WFG2","COCH","Cochlin","Predicted","2","collagen-containing extracellular matrix [GO:0062023]; collagen binding [GO:0005518]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]","GO:0005518; GO:0007605; GO:0008360; GO:0062023",NA
"389","A0A337S496","A0A337S496","COL11A1","Collagen type XI alpha 1 chain","Predicted","1","extracellular matrix structural constituent [GO:0005201]","GO:0005201",NA
"390","A0A2I2U432","A0A2I2U432","COL12A1","Collagen type XII alpha 1 chain","Predicted","1","collagen trimer [GO:0005581]; extracellular region [GO:0005576]","GO:0005576; GO:0005581",NA
"391","A0A337RZD5","A0A337RZD5","COL14A1","Collagen type XIV alpha 1 chain","Predicted","1","collagen trimer [GO:0005581]; extracellular region [GO:0005576]","GO:0005576; GO:0005581",NA
"392","A0A337RV83","A0A337RV83","COL15A1","Collagen type XV alpha 1 chain","Predicted","1","collagen trimer [GO:0005581]","GO:0005581",NA
"393","A0A5F5XC75","A0A5F5XC75","COL18A1","Collagen type XVIII alpha 1 chain","Predicted","2","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; angiogenesis [GO:0001525]; collagen fibril organization [GO:0030199]; endothelial cell morphogenesis [GO:0001886]; notochord development [GO:0030903]; skeletal system development [GO:0001501]","GO:0001501; GO:0001525; GO:0001886; GO:0005581; GO:0005615; GO:0030020; GO:0030199; GO:0030903; GO:0062023",NA
"394","M3W2F5","M3W2F5","COL1A1","Collagen type I alpha 1 chain","Predicted","5","collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to mechanical stimulus [GO:0071260]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth mineralization [GO:0034505]; visual perception [GO:0007601]","GO:0001501; GO:0001503; GO:0001568; GO:0001649; GO:0001957; GO:0001958; GO:0002020; GO:0005584; GO:0005615; GO:0005737; GO:0007601; GO:0007605; GO:0009612; GO:0010718; GO:0010812; GO:0015031; GO:0030020; GO:0030198; GO:0030199; GO:0030335; GO:0032964; GO:0034504; GO:0034505; GO:0042802; GO:0043588; GO:0043589; GO:0045893; GO:0046872; GO:0048407; GO:0048706; GO:0060325; GO:0060346; GO:0060351; GO:0062023; GO:0071230; GO:0071260; GO:0090263",NA
"395","A0A5F5XYM1","A0A5F5XYM1","COL1A2","Collagen type I alpha 2 chain","Predicted","1","extracellular matrix structural constituent [GO:0005201]","GO:0005201",NA
"396","M3WVN3","M3WVN3","COL1A2","Collagen type I alpha 2 chain","Predicted","4","collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0085029",NA
"397","M3WPE0","M3WPE0","COL28A1","Collagen type XXVIII alpha 1 chain","Predicted","2","basement membrane [GO:0005604]; collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]","GO:0004867; GO:0005588; GO:0005604; GO:0005615; GO:0007155; GO:0008201; GO:0030020; GO:0030199; GO:0062023",NA
"398","A0A5F5Y1B8","A0A5F5Y1B8","COL3A1","Collagen type III alpha 1 chain","Predicted","2","extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]","GO:0005201; GO:0046872",NA
"399","A0A5F5Y4J4","A0A5F5Y4J4","COL4A1","Collagen type IV alpha 1 chain","Predicted","2","basement membrane [GO:0005604]; collagen trimer [GO:0005581]; membrane [GO:0016020]; extracellular matrix structural constituent [GO:0005201]","GO:0005201; GO:0005581; GO:0005604; GO:0016020",NA
"400","A0A5F5XGS9","A0A5F5XGS9","COL4A2","Collagen type IV alpha 2 chain","Predicted","2","basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular space [GO:0005615]; membrane [GO:0016020]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; DNA-templated transcription [GO:0006351]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; negative regulation of angiogenesis [GO:0016525]","GO:0005587; GO:0005604; GO:0005615; GO:0006351; GO:0016020; GO:0016525; GO:0030020; GO:0030198; GO:0035987; GO:0038063; GO:0071560",NA
"401","A0A337RYM9","A0A337RYM9","COL4A3","Collagen type IV alpha 3 chain","Predicted","3","basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endothelial cell apoptotic process [GO:0072577]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of vascular endothelial cell proliferation [GO:1905563]","GO:0005178; GO:0005587; GO:0005604; GO:0005615; GO:0005783; GO:0016020; GO:0016525; GO:0030020; GO:0030198; GO:0032836; GO:0038063; GO:0072577; GO:1905563",NA
"402","A0A337SN04","A0A337SN04","COL4A5","Collagen type IV alpha 5 chain","Predicted","2","basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]","GO:0005587; GO:0005604; GO:0005615; GO:0007528; GO:0016020; GO:0030020; GO:0030198; GO:0031594; GO:0038063",NA
"403","A0A2I2UD65","A0A2I2UD65","COL5A2","Collagen type V alpha 2 chain","Predicted","3","collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; negative regulation of endodermal cell differentiation [GO:1903225]; skeletal system development [GO:0001501]; skin development [GO:0043588]","GO:0001501; GO:0005588; GO:0005615; GO:0030020; GO:0030198; GO:0030199; GO:0043588; GO:0046332; GO:0046872; GO:0048592; GO:0062023; GO:0071230; GO:1903225",NA
"404","A0A5F5XGI4","A0A5F5XGI4","COL5A3","Collagen type V alpha 3 chain","Predicted","2","collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]","GO:0005588; GO:0005615; GO:0007160; GO:0008201; GO:0030020; GO:0030198; GO:0062023",NA
"405","M3WLD9","M3WLD9","COL6A1","Collagen type VI alpha 1 chain","Predicted","5","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; intracellular vesicle [GO:0097708]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; collagen binding [GO:0005518]; platelet-derived growth factor binding [GO:0048407]; 2-oxoglutarate metabolic process [GO:0006103]; adipose tissue development [GO:0060612]; apoptotic nuclear changes [GO:0030262]; autophagy [GO:0006914]; basement membrane organization [GO:0071711]; bone development [GO:0060348]; bone mineralization [GO:0030282]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; caveola assembly [GO:0070836]; cell morphogenesis [GO:0000902]; cellular response to amino acid stimulus [GO:0071230]; circadian rhythm [GO:0007623]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endodermal cell differentiation [GO:0035987]; energy reserve metabolic process [GO:0006112]; extracellular matrix assembly [GO:0085029]; fat cell proliferation [GO:0070341]; gene expression [GO:0010467]; glycolytic process [GO:0006096]; hair follicle development [GO:0001942]; heart development [GO:0007507]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; limb joint morphogenesis [GO:0036022]; lung alveolus development [GO:0048286]; lung epithelial cell differentiation [GO:0060487]; lung morphogenesis [GO:0060425]; mitochondrial depolarization [GO:0051882]; mitochondrial transmembrane transport [GO:1990542]; mitochondrion organization [GO:0007005]; multicellular organismal locomotion [GO:0071965]; muscle cell apoptotic process [GO:0010657]; muscle system process [GO:0003012]; myelination in peripheral nervous system [GO:0022011]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein tetramerization [GO:0051262]; reactive oxygen species metabolic process [GO:0072593]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of cell size [GO:0008361]; regulation of collagen fibril organization [GO:1904026]; respiratory system process [GO:0003016]; response to bleomycin [GO:1904975]; response to decreased oxygen levels [GO:0036293]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; response to pain [GO:0048265]; response to peptide [GO:1901652]; response to polyamine macromolecule [GO:1904583]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of mechanical stimulus [GO:0050954]; single fertilization [GO:0007338]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue growth [GO:0048630]; skeletal muscle tissue regeneration [GO:0043403]; tissue remodeling [GO:0048771]; transmission of nerve impulse [GO:0019226]; tricarboxylic acid cycle [GO:0006099]; uterus development [GO:0060065]","GO:0000302; GO:0000902; GO:0001942; GO:0002023; GO:0003012; GO:0003016; GO:0005518; GO:0005576; GO:0005604; GO:0005739; GO:0005764; GO:0006096; GO:0006099; GO:0006103; GO:0006112; GO:0006914; GO:0006954; GO:0007005; GO:0007338; GO:0007507; GO:0007623; GO:0008286; GO:0008361; GO:0009410; GO:0009411; GO:0009611; GO:0009612; GO:0009636; GO:0010467; GO:0010657; GO:0014850; GO:0016529; GO:0019226; GO:0022011; GO:0030016; GO:0030199; GO:0030262; GO:0030282; GO:0032496; GO:0032963; GO:0032991; GO:0035987; GO:0036022; GO:0036293; GO:0042383; GO:0043403; GO:0043491; GO:0048009; GO:0048265; GO:0048286; GO:0048407; GO:0048630; GO:0048741; GO:0048771; GO:0048872; GO:0050954; GO:0051216; GO:0051262; GO:0051402; GO:0051882; GO:0060065; GO:0060070; GO:0060348; GO:0060425; GO:0060487; GO:0060612; GO:0062023; GO:0070341; GO:0070836; GO:0071230; GO:0071711; GO:0071965; GO:0072593; GO:0085029; GO:0097708; GO:0098528; GO:1901652; GO:1904026; GO:1904583; GO:1904975; GO:1990542",NA
"406","A0A2I2U2C4","A0A2I2U2C4","COL6A2","Collagen type VI alpha 2 chain","Predicted","2","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; response to UV [GO:0009411]","GO:0005518; GO:0005576; GO:0009411; GO:0032991; GO:0042383; GO:0043491; GO:0051402; GO:0062023",NA
"407","A0A337S4V9","A0A337S4V9","COL6A3","Collagen type VI alpha 3 chain","Predicted","2","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]","GO:0004867; GO:0005576; GO:0005581; GO:0007155",NA
"408","A0A337RW59","A0A337RW59","COL6A3","Collagen type VI alpha 3 chain","Inferred from homology","2","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]","GO:0004867; GO:0005576; GO:0005581; GO:0007155",NA
"409","M3WHG4","M3WHG4","COL6A3","Collagen type VI alpha 3 chain","Predicted","2","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; sarcolemma [GO:0042383]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; response to UV [GO:0009411]","GO:0004867; GO:0005581; GO:0005615; GO:0007155; GO:0009411; GO:0042383; GO:0043491; GO:0051402; GO:0062023",NA
"410","A0A2I2U7G3","A0A2I2U7G3","COL8A1","Collagen type VIII alpha 1 chain","Predicted","1","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; membrane [GO:0016020]","GO:0005576; GO:0005581; GO:0016020",NA
"411","A0A2I2UH03","A0A2I2UH03","COLEC10","Collectin subfamily member 10","Predicted","2","collagen trimer [GO:0005581]; extracellular space [GO:0005615]; multivesicular body [GO:0005771]; chemoattractant activity [GO:0042056]; mannose binding [GO:0005537]; complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]","GO:0001867; GO:0005537; GO:0005581; GO:0005615; GO:0005771; GO:0006508; GO:0042056; GO:1903028; GO:1904888",NA
"412","A0A2I2U3V7","A0A2I2U3V7","COLEC11","Collectin-11","Inferred from homology","2","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]","GO:0005576; GO:0005581; GO:0030246",NA
"413","A0A2I2U1P2","A0A2I2U1P2","COLEC12","Collectin-12","Predicted","3","collagen trimer [GO:0005581]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; phagocytosis, recognition [GO:0006910]; plasma membrane raft organization [GO:0044857]; toll-like receptor 3 signaling pathway [GO:0034138]","GO:0005044; GO:0005581; GO:0006910; GO:0016020; GO:0030169; GO:0030246; GO:0034138; GO:0038023; GO:0038187; GO:0042742; GO:0044857; GO:0071360",NA
"414","M3WN82","M3WN82","COLEC12","Collectin-12","Predicted","2","collagen trimer [GO:0005581]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]","GO:0005581; GO:0016020; GO:0030246",NA
"415","A0A5F5XKH5","A0A5F5XKH5","COMP","Cartilage oligomeric matrix protein","Inferred from homology","5","collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; cellular senescence [GO:0090398]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829]","GO:0002020; GO:0002063; GO:0003417; GO:0005178; GO:0005509; GO:0005518; GO:0005615; GO:0006915; GO:0006986; GO:0008201; GO:0009306; GO:0010468; GO:0014829; GO:0016485; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043395; GO:0043588; GO:0048844; GO:0050881; GO:0051260; GO:0060173; GO:0062023; GO:0070527; GO:0090398; GO:0097084; GO:1900047; GO:1902732; GO:1990079",NA
"416","A0A337S2A4","A0A337S2A4","COMP","Cartilage oligomeric matrix protein","Inferred from homology","2","extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]","GO:0005509; GO:0005576; GO:0007155",NA
"417","M3VWP9","M3VWP9","COPB2","Coatomer subunit beta'","Inferred from homology","3","COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126",NA
"418","A0A337RVF9","A0A337RVF9","COTL1","ADF-H domain-containing protein","Predicted","1","actin binding [GO:0003779]","GO:0003779",NA
"419","A0A2I2U8E4","A0A2I2U8E4","CP","ferroxidase (EC 1.16.3.1)","Inferred from homology","2","copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]","GO:0005507; GO:0016491",NA
"420","A0A5F5XZM2","A0A5F5XZM2","CPA1","Carboxypeptidase A1","Inferred from homology","1","metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0008270",NA
"421","M3WKB7","M3WKB7","CPA1","Carboxypeptidase A1 (EC 3.4.17.1)","Inferred from homology","2","extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0008270",NA
"422","A0A2I2U0Y4","A0A2I2U0Y4","CPB1","Carboxypeptidase B (EC 3.4.17.2)","Inferred from homology","2","extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0008270",NA
"423","A0A2I2UAE6","A0A2I2UAE6","CPB2","Carboxypeptidase B2","Inferred from homology","2","metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0008270; GO:0042730",NA
"424","A0A337SN31","A0A337SN31","CPD","Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D)","Inferred from homology","2","metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0008270",NA
"425","M3WGH2","M3WGH2","CPE","Carboxypeptidase E (EC 3.4.17.10) (Carboxypeptidase H) (Enkephalin convertase) (Prohormone-processing carboxypeptidase)","Inferred from homology","4","extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270]; cardiac left ventricle morphogenesis [GO:0003214]; insulin processing [GO:0030070]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055]","GO:0003214; GO:0004181; GO:0005615; GO:0005794; GO:0006518; GO:0008270; GO:0016055; GO:0016485; GO:0030070; GO:0030072; GO:0030658; GO:0030667; GO:0033366; GO:0042043; GO:0050839; GO:0072657",NA
"426","M3WMF1","M3WMF1","CPN2","Carboxypeptidase N subunit 2","Predicted","1","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]","GO:0005615; GO:0031012",NA
"427","A0A2I2V326","A0A2I2V326","CPNE1","Copine 1","Inferred from homology","1","calcium-dependent phospholipid binding [GO:0005544]","GO:0005544",NA
"428","A0A337SJW2","A0A337SJW2","CPNE3","Copine 3","Inferred from homology","1","calcium-dependent phospholipid binding [GO:0005544]","GO:0005544",NA
"429","A0A2I2U0K1","A0A2I2U0K1","CPNE4","Copine 4","Inferred from homology","1","calcium-dependent phospholipid binding [GO:0005544]","GO:0005544",NA
"430","A0A337SEH6","A0A337SEH6","CPXM2","Carboxypeptidase X, M14 family member 2","Inferred from homology","2","extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]","GO:0004181; GO:0005576; GO:0006508; GO:0008270",NA
"431","U5TLB4","U5TLB4","CPXV028","CPXV028 protein","Predicted","1",NA,NA,NA
"432","A0A0K2YWB3","A0A0K2YWB3","CPXV211","CPXV211 protein","Predicted","1",NA,NA,NA
"433","A0A337SSG2","A0A337SSG2","CPZ","Carboxypeptidase Z","Inferred from homology","2","metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0008270",NA
"434","A0A337SJR3","A0A337SJR3","CR2","Complement C3d receptor 2","Predicted","1","membrane [GO:0016020]","GO:0016020",NA
"435","A0A337SV16","A0A337SV16","CRB1","Crumbs cell polarity complex component 1","Predicted","2","membrane [GO:0016020]; calcium ion binding [GO:0005509]","GO:0005509; GO:0016020",NA
"436","A0A337SRL8","A0A337SRL8","CRB2","Crumbs cell polarity complex component 2","Predicted","2","membrane [GO:0016020]; calcium ion binding [GO:0005509]","GO:0005509; GO:0016020",NA
"437","A0A5F5XYI6","A0A5F5XYI6","CREB3L2","Cyclic AMP-responsive element-binding protein 3-like protein 2","Inferred from homology","3","endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]","GO:0000981; GO:0001228; GO:0002062; GO:0005654; GO:0005783; GO:0006357; GO:0006888; GO:0016020; GO:0034976; GO:0035497",NA
"438","M3WK50","M3WK50","CREB3L3","cAMP responsive element binding protein 3 like 3","Inferred from homology","2","endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]","GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005789; GO:0006357; GO:0006986; GO:0034976; GO:0042803; GO:0046982",NA
"439","A0A5F5XJY1","A0A5F5XJY1","CREG1","Cellular repressor of E1A stimulateds 1","Inferred from homology","1","extracellular space [GO:0005615]","GO:0005615",NA
"440","A0A337S172","A0A337S172","CRIM1","Cysteine rich transmembrane BMP regulator 1","Predicted","1","extracellular region [GO:0005576]; membrane [GO:0016020]; serine-type endopeptidase inhibitor activity [GO:0004867]","GO:0004867; GO:0005576; GO:0016020",NA
"441","M3WNB8","M3WNB8","CRIP1","Cysteine rich protein 1","Predicted","2","cytoplasm [GO:0005737]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; prostate gland stromal morphogenesis [GO:0060741]; regulation of gene expression [GO:0010468]; response to organic substance [GO:0010033]; response to zinc ion [GO:0010043]","GO:0005737; GO:0006955; GO:0008270; GO:0008630; GO:0010033; GO:0010043; GO:0010468; GO:0042277; GO:0060741; GO:0071236; GO:0071493",NA
"442","A0A2I2UC81","A0A2I2UC81","CRISP3","Cysteine rich secretory protein 3","Inferred from homology","1","extracellular region [GO:0005576]","GO:0005576",NA
"443","A0A5F5XVE8","A0A5F5XVE8","CRISP3","Cysteine rich secretory protein 3","Inferred from homology","1","extracellular region [GO:0005576]","GO:0005576",NA
"444","A0A5F5Y1N6","A0A5F5Y1N6","CRISP3","Cysteine rich secretory protein 3","Inferred from homology","2","extracellular space [GO:0005615]; specific granule [GO:0042581]","GO:0005615; GO:0042581",NA
"445","A0A337SBA6","A0A337SBA6","CRK","Adapter molecule crk","Inferred from homology","5","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ephrin receptor binding [GO:0046875]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; negative regulation of cell motility [GO:2000146]; negative regulation of wound healing [GO:0061045]; neuron migration [GO:0001764]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of T cell migration [GO:2000404]","GO:0001764; GO:0001784; GO:0005737; GO:0005886; GO:0006629; GO:0007167; GO:0008283; GO:0008360; GO:0015629; GO:0016358; GO:0016477; GO:0017124; GO:0021766; GO:0021987; GO:0030010; GO:0030036; GO:0030159; GO:0030971; GO:0031594; GO:0031625; GO:0032956; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042169; GO:0046875; GO:0048013; GO:0050773; GO:0060326; GO:0061045; GO:0098698; GO:0098749; GO:1900026; GO:1904395; GO:2000146; GO:2000404",NA
"446","M3W544","M3W544","CRKL","CRK like proto-oncogene, adaptor protein","Inferred from homology","5","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591]; acetylcholine receptor signaling pathway [GO:0095500]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of T cell migration [GO:2000404]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655]","GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0001933; GO:0001934; GO:0003151; GO:0005654; GO:0005737; GO:0005829; GO:0006629; GO:0007167; GO:0007283; GO:0007338; GO:0008284; GO:0008543; GO:0008584; GO:0009952; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0086100; GO:0095500; GO:0098698; GO:0098749; GO:0098761; GO:0098890; GO:0160093; GO:1900026; GO:1903977; GO:1904395; GO:1904888; GO:2000404",NA
"447","A0A5F5XWB9","A0A5F5XWB9","CRP","Pentraxin family member","Inferred from homology","3","extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; acute-phase response [GO:0006953]; innate immune response [GO:0045087]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; positive regulation of gene expression [GO:0010628]; positive regulation of superoxide anion generation [GO:0032930]; regulation of interleukin-8 production [GO:0032677]; vasoconstriction [GO:0042310]","GO:0001849; GO:0005509; GO:0005615; GO:0006953; GO:0010628; GO:0010745; GO:0010888; GO:0030169; GO:0032677; GO:0032930; GO:0032945; GO:0042310; GO:0042802; GO:0045087; GO:0050750",NA
"448","A0A2I2UDI7","A0A2I2UDI7","CRTAC1","Cartilage acidic protein 1","Predicted","1","calcium ion binding [GO:0005509]; axonal fasciculation [GO:0007413]","GO:0005509; GO:0007413",NA
"449","A0A5F5XI25","A0A5F5XI25","CRYL1","L-gulonate 3-dehydrogenase (EC 1.1.1.45) (L-gulonate 3-dehydrogenase)","Inferred from homology","2","NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; fatty acid metabolic process [GO:0006631]","GO:0006631; GO:0016616; GO:0070403",NA
"450","A0A5F5XUR3","A0A5F5XUR3","CRYM","Ketimine reductase mu-crystallin (EC 1.5.1.25) (NADP-regulated thyroid-hormone-binding protein)","Inferred from homology","2","thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]","GO:0047127",NA
"451","A0A337SVX9","A0A337SVX9","CRYZ","Crystallin zeta","Inferred from homology","1","oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]","GO:0003723; GO:0008270; GO:0016491",NA
"452","A0A337SMK6","A0A337SMK6","CSF1","Colony stimulating factor 1","Predicted","2","membrane [GO:0016020]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]","GO:0005125; GO:0008083; GO:0016020",NA
"453","P13369","P13369","CSF1R FMS","Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115)","Evidence at transcript level","5","cell surface [GO:0009986]; CSF1-CSF1R complex [GO:1990682]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; macrophage colony-stimulating factor receptor activity [GO:0005011]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to cytokine stimulus [GO:0071345]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; osteoclast differentiation [GO:0030316]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of cell shape [GO:0008360]; regulation of macrophage migration [GO:1905521]; regulation of MAPK cascade [GO:0043408]; ruffle organization [GO:0031529]","GO:0005011; GO:0005524; GO:0005886; GO:0006954; GO:0007169; GO:0008284; GO:0008360; GO:0009986; GO:0018108; GO:0019838; GO:0019955; GO:0030316; GO:0030335; GO:0031529; GO:0032956; GO:0036006; GO:0042531; GO:0043235; GO:0043408; GO:0045087; GO:0045124; GO:0046777; GO:0051897; GO:0070374; GO:0071345; GO:1905521; GO:1990682",NA
"454","M3WGW7","M3WGW7","CSPG4","Chondroitin sulfate proteoglycan 4","Predicted","3","nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; coreceptor activity [GO:0015026]; protein kinase binding [GO:0019901]; glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]","GO:0001726; GO:0005654; GO:0005886; GO:0006929; GO:0008347; GO:0015026; GO:0019901; GO:0035556; GO:0043410; GO:0048008; GO:0050731; GO:0097178",NA
"455","D5MTH1","D5MTH1","CST3","Cystatin C","Evidence at transcript level","3","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; amyloid-beta binding [GO:0001540]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; defense response [GO:0006952]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of collagen catabolic process [GO:0010711]; negative regulation of elastin catabolic process [GO:0060311]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of proteolysis [GO:0045861]; supramolecular fiber organization [GO:0097435]","GO:0001540; GO:0002020; GO:0004869; GO:0005615; GO:0005737; GO:0005794; GO:0005886; GO:0006952; GO:0010711; GO:0010716; GO:0031982; GO:0042802; GO:0045861; GO:0060311; GO:0060313; GO:0097435",NA
"456","M3WIK5","M3WIK5","CST6","Cystatin E/M","Inferred from homology","2","cornified envelope [GO:0001533]; extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; epidermis development [GO:0008544]","GO:0001533; GO:0004869; GO:0005576; GO:0008544",NA
"457","Q8WNR9","Q8WNR9","CSTA","Cystatin-A (allergen Fel d 3)","Evidence at protein level","2","cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]","GO:0004869; GO:0005829",NA
"458","A0A337SE08","A0A337SE08","CSTB","Cystatin domain-containing protein","Inferred from homology","1","cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity [GO:0004869]","GO:0004869; GO:0005737",NA
"459","A0A337SJE3","A0A337SJE3","CTH","Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase)","Inferred from homology","2","cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process [GO:0019344]; transsulfuration [GO:0019346]","GO:0004123; GO:0019344; GO:0019346; GO:0030170; GO:0044540; GO:0080146",NA
"460","A0A337SHY2","A0A337SHY2","CTHRC1","Collagen triple helix repeat containing 1","Predicted","1",NA,NA,NA
"461","A0A2I2U5B1","A0A2I2U5B1","CTNNB1","Catenin beta-1 (Beta-catenin)","Inferred from homology","2","adherens junction [GO:0005912]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]","GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0045296",NA
"462","A0A5F5XDM8","A0A5F5XDM8","CTRC","Chymotrypsin C","Predicted","1","serine-type endopeptidase activity [GO:0004252]; intracellular calcium ion homeostasis [GO:0006874]; proteolysis [GO:0006508]","GO:0004252; GO:0006508; GO:0006874",NA
"463","M3W019","M3W019","CTRC","Chymotrypsin C","Predicted","1","serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]","GO:0004252; GO:0006508",NA
"464","M3WHR1","M3WHR1","CTRL","Chymotrypsin like","Predicted","1","extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508",NA
"465","A0A337SMR1","A0A337SMR1","CTSA","Carboxypeptidase (EC 3.4.16.-)","Inferred from homology","2","serine-type carboxypeptidase activity [GO:0004185]; proteolysis [GO:0006508]","GO:0004185; GO:0006508",NA
"466","M3WLU0","M3WLU0","CTSB","Cathepsin B (EC 3.4.22.1)","Inferred from homology","4","apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; proteoglycan binding [GO:0043394]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590]","GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090",NA
"467","M3W9M0","M3W9M0","CTSC","Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (Dipeptidyl transferase)","Inferred from homology","4","centrosome [GO:0005813]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; dipeptidyl-peptidase activity [GO:0008239]; peptidase activator activity involved in apoptotic process [GO:0016505]; serine-type endopeptidase activity [GO:0004252]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005764; GO:0005813; GO:0008239; GO:0016505; GO:0031642; GO:0051603; GO:1903980; GO:2001235",NA
"468","M3W8G3","M3W8G3","CTSD","Cathepsin D (EC 3.4.23.5)","Inferred from homology","3","endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; aspartic-type endopeptidase activity [GO:0004190]; autophagosome assembly [GO:0000045]; insulin catabolic process [GO:1901143]; insulin receptor recycling [GO:0038020]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]","GO:0000045; GO:0004190; GO:0005615; GO:0005765; GO:0006508; GO:0010008; GO:0031904; GO:0038020; GO:0042159; GO:0043065; GO:0045121; GO:0070201; GO:1901143",NA
"469","M3W7M8","M3W7M8","CTSF","Cathepsin F","Inferred from homology","2","endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0005783; GO:0005886; GO:0051603",NA
"470","M3WGI2","M3WGI2","CTSH","Pro-cathepsin H","Inferred from homology","2","lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; proteolysis [GO:0006508]","GO:0005764; GO:0006508; GO:0008234",NA
"471","A0A337SUC3","A0A337SUC3","CTSH","Pro-cathepsin H","Inferred from homology","2","lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; proteolysis [GO:0006508]","GO:0005764; GO:0006508; GO:0008234",NA
"472","M3W0Q2","M3W0Q2","CTSK","Cathepsin K (EC 3.4.22.38)","Inferred from homology","4","apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; immune response [GO:0006955]; negative regulation of cartilage development [GO:0061037]; positive regulation of apoptotic signaling pathway [GO:2001235]; proteolysis involved in protein catabolic process [GO:0051603]; thyroid hormone generation [GO:0006590]","GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005764; GO:0006590; GO:0006955; GO:0008656; GO:0009897; GO:0016324; GO:0030574; GO:0043394; GO:0045453; GO:0051603; GO:0061037; GO:2001235",NA
"473","M3WUC1","M3WUC1","CTSO","Cathepsin O","Inferred from homology","2","extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0051603",NA
"474","A0A337RZ12","A0A337RZ12","CTSS","Cathepsin S","Inferred from homology","1","cysteine-type peptidase activity [GO:0008234]; proteolysis [GO:0006508]","GO:0006508; GO:0008234",NA
"475","M3W0Q1","M3W0Q1","CTSS","Cathepsin S (EC 3.4.22.27)","Inferred from homology","4","extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; collagen binding [GO:0005518]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; basement membrane disassembly [GO:0034769]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; immune response [GO:0006955]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein processing [GO:0016485]; proteolysis involved in protein catabolic process [GO:0051603]; response to acidic pH [GO:0010447]","GO:0001968; GO:0002250; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0005770; GO:0006955; GO:0008656; GO:0010447; GO:0016485; GO:0019886; GO:0030574; GO:0034769; GO:0043236; GO:0043394; GO:0045335; GO:0051603; GO:0097067; GO:2001235",NA
"476","A0A5F5XBP7","A0A5F5XBP7","CTSZ","cathepsin X (EC 3.4.18.1)","Inferred from homology","2","membrane [GO:0016020]; cysteine-type peptidase activity [GO:0008234]; proteolysis [GO:0006508]","GO:0006508; GO:0008234; GO:0016020",NA
"477","M3VVI7","M3VVI7","CTSZ","cathepsin X (EC 3.4.18.1)","Inferred from homology","3","cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004180; GO:0004197; GO:0005615; GO:0005764; GO:0005783; GO:0005938; GO:0010757; GO:0016020; GO:0031410; GO:0051603; GO:0060441",NA
"478","M3WJ25","M3WJ25","CUBN","Cubilin","Predicted","3","apical plasma membrane [GO:0016324]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]","GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0009235; GO:0009617; GO:0015889; GO:0016324; GO:0030139; GO:0031528; GO:0038024; GO:0042803; GO:0042953; GO:0043235; GO:0051649; GO:0070062",NA
"479","A0A2I2UJG2","A0A2I2UJG2","CUTA","CutA divalent cation tolerance homolog","Inferred from homology","1","response to metal ion [GO:0010038]","GO:0010038",NA
"480","A0A2I2UQ66","A0A2I2UQ66","CXADR","CXADR Ig-like cell adhesion molecule","Predicted","2","adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; plasma membrane [GO:0005886]","GO:0005886; GO:0005912; GO:0005923",NA
"481","O62657","O62657","CXCL12 SDF1","Stromal cell-derived factor 1 (SDF-1) (C-X-C motif chemokine 12)","Inferred from homology","4","external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; CXCR chemokine receptor binding [GO:0045236]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; chemokine-mediated signaling pathway [GO:0070098]; defense response [GO:0006952]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; integrin activation [GO:0033622]","GO:0005178; GO:0005615; GO:0006952; GO:0006955; GO:0007411; GO:0008009; GO:0008083; GO:0009897; GO:0033622; GO:0042379; GO:0045236; GO:0050930; GO:0060326; GO:0070098",NA
"482","M3WSR7","M3WSR7","CXCL16","C-X-C motif chemokine 16 (Transmembrane chemokine CXCL16)","Inferred from homology","3","extracellular space [GO:0005615]; membrane [GO:0016020]; chemokine activity [GO:0008009]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; receptor-mediated endocytosis [GO:0006898]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; T cell chemotaxis [GO:0010818]","GO:0005041; GO:0005044; GO:0005615; GO:0006898; GO:0008009; GO:0010818; GO:0016020; GO:0030307; GO:0030335; GO:0034341; GO:0034612",NA
